DENTSPLY INTERNATIONAL INC. DEF 14A
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
(RULE 14a-101)
INFORMATION REQUIRED IN PROXY STATEMENT
SCHEDULE 14A INFORMATION
PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES
EXCHANGE ACT OF 1934 (AMENDMENT NO. )
Filed by the Registrant þ
Filed by a Party other than the Registrant o
Check the appropriate box:
o |
|
Preliminary Proxy Statement |
o |
|
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
þ |
|
Definitive Proxy Statement |
o |
|
Definitive Additional Materials |
o |
|
Soliciting Material Pursuant to Section 240.14a-11c or
Section 240.14a-12 |
DENTSPLY INTERNATIONAL INC.
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
þ |
|
No fee required. |
|
o |
|
Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. |
|
(1) |
|
Title of each class of securities to which transaction applies: |
|
|
|
|
|
|
|
|
|
|
|
(2) |
|
Aggregate number of securities to which transaction applies: |
|
|
|
|
|
|
|
|
|
|
|
(3) |
|
Per unit price or other underlying value of transaction computed pursuant to Exchange Act
Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was
determined): |
|
|
|
|
|
|
|
|
|
|
|
(4) |
|
Proposed maximum aggregate value of transaction: |
|
|
|
|
|
|
|
|
|
|
|
(5) |
|
Total fee paid: |
|
|
|
|
|
|
|
|
|
o |
|
Fee paid previously with preliminary materials. |
|
o |
|
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2)
and identify the filing for which the offsetting fee was paid previously. Identify the
previous filing by registration statement number, or the Form or Schedule and the date of its
filing. |
|
(1) |
|
Amount Previously Paid: |
|
|
|
|
|
|
|
|
|
|
|
(2) |
|
Form, Schedule or Registration Statement No.: |
|
|
|
|
|
|
|
|
|
|
|
(3) |
|
Filing Party: |
|
|
|
|
|
|
|
|
|
|
|
(4) |
|
Date Filed: |
|
|
|
|
|
|
|
|
|
DENTSPLY
International Inc.
World
Headquarters
Susquehanna
Commerce Center
221 W. Philadelphia
Street
York,
PA 17405-0872
(717) 845-7511
Fax
(717) 854-2343
April 11,
2008
Dear
DENTSPLY Stockholder:
You are cordially invited to attend the 2008 Annual Meeting of
Stockholders to be held on Tuesday, May 13, 2008, at
9:30 a.m., at the Companys Employee Meeting Room at
570 West College Avenue, in York, Pennsylvania.
The Annual Meeting will include voting on the matters described
in the accompanying Notice of Annual Meeting and Proxy
Statement, a report on Company operations, and discussion.
Whether or not you plan to attend, you can ensure that your
shares are represented at the Annual Meeting by voting your
proxy. You have three ways to vote your proxy. You may vote by
mail by promptly completing, signing, dating and returning the
enclosed proxy card in the envelope provided, you may vote by
telephone by calling
1-800-690-6903
and following the instructions, or you may vote by internet by
following the instructions on the proxy card or going to the
internet at www.proxyvote.com and following the
instructions on that site. Your vote is important. Please take a
moment to vote through one of the above methods.
Sincerely,
Bret W. Wise
Chairman of the Board,
Chief Executive Officer and President
DENTSPLY
INTERNATIONAL INC.
SUSQUEHANNA COMMERCE CENTER
221 WEST PHILADELPHIA STREET
YORK, PENNSYLVANIA
17405-0872
NOTICE OF
ANNUAL MEETING OF STOCKHOLDERS
TO BE HELD ON TUESDAY, MAY 13, 2008
The Annual Meeting of Stockholders (the Annual
Meeting) of DENTSPLY International Inc., a Delaware
corporation (the Company), will be held on Tuesday,
May 13, 2008, at 9:30 a.m., local time, at the
Companys Employee Meeting Room, 570 West College
Avenue, York, Pennsylvania, for the following purposes:
1. To elect four Class I directors to serve for a term
of three years and until their respective successors are duly
elected and qualified;
2. To ratify the appointment of PricewaterhouseCoopers LLP,
independent registered public accounting firm, to audit the
books and accounts of the Company for the year ending
December 31, 2008;
3. If properly presented at the meeting, to vote on a
shareholder proposal requesting the Company to prepare a
sustainability report; and
4. To transact such other business as may properly come
before the Annual Meeting and any and all adjournments and
postponements thereof.
The Board of Directors fixed the close of business on
March 17, 2008 as the record date for the determination of
stockholders entitled to notice of and to vote at the Annual
Meeting and any adjournment or postponement thereof.
The enclosed proxy is solicited by the Board of Directors of the
Company. Reference is made to the accompanying Proxy Statement
for further information with respect to the business to be
transacted at the Annual Meeting.
A complete list of the stockholders entitled to vote at the
Annual Meeting will be available during ordinary business hours
for examination by any stockholder, for any purpose germane to
the Annual Meeting, for a period of at least ten days prior to
the Annual Meeting, at the office of the Companys
Secretary, Susquehanna Commerce Center, 221 West
Philadelphia Street, York, Pennsylvania.
The Board of Directors urges you to vote your proxy by mail,
by telephone or through the internet. You are cordially invited
to attend the Annual Meeting in person. The voting of your proxy
will not affect your right to revoke your proxy or to vote in
person if you do attend the Annual Meeting.
By Order of the Board of Directors,
Brian M. Addison
Vice President, Secretary and
General Counsel
York, Pennsylvania
April 11, 2008
YOUR VOTE
IS IMPORTANT, NO MATTER HOW MANY SHARES YOU
OWNED ON THE RECORD DATE.
PLEASE INDICATE YOUR VOTING INSTRUCTIONS ON THE ENCLOSED
PROXY CARD, DATE AND SIGN IT, AND RETURN IT IN THE ENVELOPE
PROVIDED, WHICH IS ADDRESSED FOR YOUR CONVENIENCE AND NEEDS NO
POSTAGE IF MAILED IN THE UNITED STATES. OR, IF YOU WISH,
YOU MAY PROVIDE YOUR PROXY INSTRUCTION USING THE TELEPHONE
BY CALLING
1-800-690-6903,
OR THE INTERNET BY FOLLOWING THE INSTRUCTIONS ON THE
ENCLOSED PROXY CARD. IN ORDER TO AVOID THE ADDITIONAL EXPENSE TO
THE COMPANY OF FURTHER SOLICITATION, WE ASK YOUR COOPERATION IN
VOTING YOUR PROXY PROMPTLY.
DENTSPLY
INTERNATIONAL INC.
SUSQUEHANNA COMMERCE CENTER
221 WEST PHILADELPHIA STREET
YORK, PENNSYLVANIA
17405-0872
Table
of Contents
|
|
|
|
|
|
|
|
1
|
|
|
|
|
2
|
|
|
|
|
6
|
|
|
|
|
7
|
|
|
|
|
10
|
|
|
|
|
11
|
|
|
|
|
12
|
|
|
|
|
12
|
|
|
|
|
13
|
|
|
|
|
22
|
|
|
|
|
35
|
|
|
|
|
37
|
|
|
|
|
41
|
|
|
|
|
41
|
|
|
|
|
42
|
|
|
|
|
42
|
|
|
|
|
43
|
|
|
|
|
43
|
|
|
|
|
43
|
|
|
|
|
A-1
|
|
|
|
|
B-1
|
|
|
|
|
C-1
|
|
|
|
|
D-1
|
|
DENTSPLY
INTERNATIONAL INC.
SUSQUEHANNA COMMERCE CENTER
221 WEST PHILADELPHIA STREET
YORK, PENNSYLVANIA
17405-0872
PROXY
STATEMENT
GENERAL
INFORMATION
This Proxy Statement is furnished in connection with the
solicitation of proxies by the Board of Directors of DENTSPLY
International Inc., a Delaware corporation (DENTSPLY
or the Company), for use at the Companys 2008
Annual Meeting of Stockholders (together with any and all
adjournments and postponements thereof, the Annual
Meeting) to be held on Tuesday, May 13, 2008, at
9:30 a.m., local time, at the Companys Employee
Meeting Room, 570 West College Avenue, York, Pennsylvania,
for the purposes set forth in the accompanying Notice of Annual
Meeting of Stockholders. This Proxy Statement, together with the
foregoing Notice and the enclosed proxy card, are first being
sent to stockholders on or about April 11, 2008.
The Board of Directors (the Board) fixed the close
of business on March 17, 2008 as the record date for the
determination of stockholders entitled to notice of and to vote
at the Annual Meeting. On the record date, there were
148,791,129 shares of Common Stock of the Company, par
value $.01 per share (Common Stock), outstanding and
entitled to vote. Each share of Common Stock is entitled to one
vote per share on each matter properly brought before the Annual
Meeting. Shares can be voted at the Annual Meeting only if the
stockholder is present in person or is represented by proxy. The
presence, in person or by proxy at the Annual Meeting, of shares
of Common Stock representing at least a majority of the total
number of shares of Common Stock outstanding on the record date
will constitute a quorum for purposes of the Annual Meeting.
Whether or not you are able to attend the Annual Meeting, you
are urged to vote your proxy, either by mail, telephone or the
internet, which is solicited by the Companys Board of
Directors and which will be voted as you direct. In the absence
of instructions, shares represented by properly provided proxies
will be voted as recommended by the Board of Directors.
Any proxy may be revoked at any time prior to its exercise by
attending the Annual Meeting and voting in person, by notifying
the Secretary of the Company of such revocation in writing or by
delivering a duly executed proxy bearing a later date, provided
that such notice or proxy is actually received by the Company
prior to the taking of any vote at the Annual Meeting.
The cost of solicitation of proxies for use at the Annual
Meeting and sought by the Board of Directors will be borne by
the Company. Solicitations will be made primarily by mail,
facsimile or through the internet, and employees or agents of
the Company may solicit proxies personally or by telephone for
no additional consideration. The Company may specifically engage
a firm to assist in the solicitation of proxies on behalf of the
Board and would anticipate paying a reasonable fee for such
services plus reasonable out-of-pocket expenses.
Brokers, banks and other nominee holders will be requested to
obtain voting instructions of beneficial owners of stock
registered in their names. The Company will reimburse these
record holders for their reasonable out-of-pocket expenses
incurred in doing so. Shares represented by a duly completed
proxy submitted by a nominee holder on behalf of beneficial
owners will be counted for quorum purposes, and will be voted to
the extent instructed by the nominee holder on the proxy card or
through the internet. The rules applicable to a nominee holder
may preclude it from voting the shares that it holds on certain
kinds of proposals unless it receives voting instructions from
the beneficial owners of the shares (sometimes referred to as
broker non-votes).
ELECTION
OF DIRECTORS
The Restated Certificate of Incorporation and the by-laws of the
Company provide that the number of directors (which is to be not
less than three) is to be determined from time to time by the
Board of Directors. The Board is currently comprised of eleven
persons.
Pursuant to the Companys Restated Certificate of
Incorporation, the members of the Board of Directors are divided
into three classes. Each class is to consist, as nearly as may
be possible, of one-third of the whole number of members of the
Board. The term of the Class I directors expires at the
Annual Meeting. The terms of the Class II and
Class III directors will expire at the 2009 and 2010 Annual
Meetings of Stockholders, respectively. At each Annual Meeting,
the directors elected to succeed those whose terms expire are of
the same class as the directors they succeed and are elected for
a term to expire at the third Annual Meeting of Stockholders
after their election and until their successors are duly elected
and qualified. A director elected to fill a vacancy is elected
to the same class as the director
he/she
succeeds, and a director elected to fill a newly created
directorship holds office until the next election of the class
to which such director is elected.
The four incumbent Class I directors are nominees for
election to the Board this year for a three-year term expiring
at the 2011 Annual Meeting of Stockholders. In the election, the
four persons who receive the highest number of votes actually
cast will be elected. The proxy named in the proxy card and on
the internet voting site intends to vote for the election of the
four Class I nominees listed below unless otherwise
instructed. If a holder does not wish his or her shares to be
voted for a particular nominee, the holder must identify the
exception in the appropriate space provided on the proxy card or
on the internet site, in which event the shares will be voted
for the other listed nominees. If any nominee becomes unable to
serve, the proxy may vote for another person designated by the
Board of Directors or the Board may reduce the number of
directors. The Company has no reason to believe that any nominee
will be unable to serve.
The Companys by-laws require that stockholders seeking to
nominate persons for election to the Board, or to propose other
business to be brought before an Annual Meeting of Stockholders,
comply with certain procedures. See Stockholder Proposals
for Proxy Statement and Nominations in this Proxy
Statement.
Set forth below is certain information with regard to each of
the nominees for election as Class I directors and each
continuing Class II and Class III director.
Nominees
for Election as Class I Directors
|
|
|
Name and Age
|
|
Principal Occupation and Directorships
|
|
Michael C. Alfano, D.M.D., Ph.D.
Age 60
|
|
Dr. Alfano is Executive Vice President at New York
University where he is responsible for Finance, Budget,
Endowment, Real Estate, Facilities, Treasury and Human
Resources. He is also Professor of Basic Science and
Craniofacial Biology at the NYU College of Dentistry since 1998,
where he served as Dean until 2006. Beginning in 1982 until 1998
he held a number of positions with Block Drug Company, including
Senior Vice President for Research & Technology and
President of Block Professional Dental Products Company. He
served on the Board of Directors of Block Drug Company, Inc.
from 1988 to 1998. He serves as a member of or consultant to
various public health organizations, including the Editorial
Board of the American Journal of Dentistry since 1987, and
served on the Board of Overseers for the School of Dental
Medicine at the University of Pennsylvania from 1992 to 2004. In
addition, Dr. Alfano has served as a consultant to the
Consumer Healthcare Product Association and as the industry
representative to the Non-Prescription Drugs Advisory Committee
of the FDA from 2001 to 2005. He is a founding director of the
Friends of the National Institute for Dental and Craniofacial
Research, and he is a founding director of the not-for-profit
Santa Fe Group. He was also a Trustee of the New York State
Dental Foundation until 2006. Dr. Alfano was appointed to
the DENTSPLY Board of Directors in February 2001.
|
2
|
|
|
Name and Age
|
|
Principal Occupation and Directorships
|
|
|
|
|
Eric K. Brandt
Age 45
|
|
Mr. Brandt was appointed Senior Vice President and Chief
Financial Officer of Broadcom Corporation in March 2007. From
September 2005 until March 2007, he served as President and
Chief Executive Officer at Avanir Pharmaceuticals. Beginning in
1999, he held various positions at Allergan, Inc., including
Corporate Vice President and Chief Financial Officer until 2001,
President of Consumer Eye Care from 2001 to 2002, and in 2005,
until his departure, Executive Vice President of Finance and
Technical Operations and Chief Financial Officer. Prior to
joining Allergan, he was Vice President and Partner at Boston
Consulting Group, and a senior member of the BCG Health Care and
Operations practices. He currently serves on the Board of Vertex
Pharmaceuticals, Inc. Mr. Brandt was appointed to the DENTSPLY
Board of Directors in November 2004.
|
|
|
|
William F. Hecht
Age 65
|
|
Mr. Hecht retired as Chairman of the Board and Chief Executive
Officer of PPL Corporation, a diversified utility and energy
services company, on October 1, 2006. He was elected President
and Chief Operating Officer in 1991 and Chairman and Chief
Executive Officer in 1993. In addition to PPL Corporation, he
served on the Boards of PPL Electric Utilities Corporation and
PPL Energy Supply, LLC, subsidiaries of PPL Corporation. Mr.
Hecht also serves as Chairman of the Board of Directors of the
Federal Reserve Bank of Philadelphia and as a director of
RenaissanceRe Holdings Ltd. He also serves on the Board of a
number of civic and charitable organizations. Mr. Hecht was
appointed to the DENTSPLY Board of Directors in March 2001.
|
|
|
|
Francis J. Lunger
Age 62
|
|
Mr. Lunger served on the Board of Millipore Corporation from
2001 until March 2005, including serving as Chairman from April
2002 until April 2004. Mr. Lunger joined Millipore in 1997 as
Senior Vice President and Chief Financial Officer and held
several executive management positions, which included serving
as Executive Vice President and Chief Operating Officer from
2000 until 2001, and President and Chief Executive Officer from
August 2001 until January 2005. Prior to joining Millipore, Mr.
Lunger held executive management positions at Oak Industries,
Inc., Nashua Corporation, and Raychem Corporation. In June 2007,
he was elected to the board of NDS Surgical Imaging. Mr. Lunger
was elected to the DENTSPLY Board of Directors in May 2005.
|
Directors
Continuing as Class II Directors
|
|
|
Name and Age
|
|
Principal Occupation and Directorships
|
|
Wendy L. Dixon, Ph.D.
Age 52
|
|
Dr. Dixon serves as the President of Global Marketing and
Chief Marketing Officer at Bristol-Myers Squibb Company
(Bristol-Myers),
a position she has held since joining the company in December
2001. She also serves on the Executive Committee of
Bristol-Myers. From 1996 to November 2001, Dr. Dixon held
executive management positions at Merck & Company, most
recently serving as the Senior Vice President of Marketing.
Prior to her employment at Merck, Dr. Dixon held executive
management positions with Osteotech and Centocor and various
positions at SmithKline in marketing, regulatory affairs and
project management. Dr. Dixon was appointed to the DENTSPLY
Board of Directors in July 2005.
|
3
|
|
|
Name and Age
|
|
Principal Occupation and Directorships
|
|
|
|
|
Leslie A. Jones
Age 68
|
|
Mr. Jones served as Chairman of the Board of the Company from
May 1996 to May 1998. From January 1991 to January 1992, he
was a Senior Vice President and Special Assistant to the
President of Dentsply International Inc. (Old
Dentsply) prior to its merger with Gendex Corporation
(Gendex) on June 11, 1993 (the Merger).
Prior to that time, Mr. Jones served as Senior Vice President of
North American Operations. Mr. Jones has served as a director of
the Company since the Merger, and prior to the Merger served as
a director of Old Dentsply.
|
|
|
|
Bret W. Wise
Age 47
|
|
Mr. Wise is the Chairman, Chief Executive Officer and President
of the Company, positions he has held since January 2007. Mr.
Wise joined DENTSPLY in November 2002 as Senior Vice President
and Chief Financial Officer. In January 2005, he was promoted to
Executive Vice President with operating oversight responsibility
for two of DENTSPLYs four operating groups, corporate
research and development, and business development activities.
In January 2006, Mr. Wise was promoted to President and Chief
Operating Officer, positions he held until being appointed to
his current role. Prior to joining DENTSPLY, Mr. Wise was
Senior Vice President and Chief Financial Officer of Ferro
Corporation. He was also formerly Vice President and Chief
Financial Officer of WCI Steel, Inc. and a partner with the
accounting and consulting firm of KPMG. Mr. Wise currently
serves on the boards of the National Foundation of Dentistry for
the Handicapped and IMS Health. He joined the DENTSPLY Board of
Directors in August 2006 and was named Chairman of the Board in
January 2007.
|
Directors
Continuing as Class III Directors
|
|
|
Name and Age
|
|
Principal Occupation and Directorships
|
|
Paula H. Cholmondeley
Age 60
|
|
Ms. Cholmondeley is a private consultant on Strategic Planning.
She served as the Vice President and General Manager of
Specialty Products for Sappi Fine Paper, a subsidiary of Sappi
Limited from April 2000 until January 2004, and prior to that
from January 1998 until April 2000, she was a private consultant
on Strategic Planning and Mergers and Acquisitions. From 1992
until January 1998, Ms. Cholmondeley held various
management positions with Owens Corning, including General
Manager of Residential Insulation. Ms. Cholmondeley served
as a White House Fellow and a Special Assistant to the U.S.
Trade Representative for several countries in the Far East from
1982 to 1983. She has also held a number of significant
positions with other companies including managerial positions
with Westinghouse Elevator Company, and as Chief Financial
Officer and Senior Vice President for Blue Cross of Greater
Philadelphia. She is an independent trustee of Nationwide Mutual
Fund. She also serves on the Boards of Terex Corporation,
Ultralife Batteries, Albany International, and Minerals
Technologies, Inc. Ms. Cholmondeley was appointed to the
DENTSPLY Board of Directors in September 2001.
|
4
|
|
|
Name and Age
|
|
Principal Occupation and Directorships
|
|
|
|
|
Michael J. Coleman
Age 64
|
|
Mr. Coleman is the Chairman of the Board of Cool Media Company
and a partner in CS&W Associates Media Management, both
based in Cocoa Beach, Florida. He served as Chairman of Cape
Publications in Melbourne, Florida until retiring from that
position on January 1, 2007. He previously served as Publisher
of FLORIDA TODAY and President of the Gannett Co., Inc., South
Newspaper Group from 1991 to April 2006. He serves as a director
of Ron Jon Surf Shops Worldwide, Prime Bank of Melbourne,
Florida, and as a Trustee of the Freedom Forum Diversity
Institute, based in Nashville, Tennessee and The Newseum in
Washington, D.C. Mr. Coleman has served as a director of
the Company since the Merger, and prior thereto as a director of
Gendex.
|
|
|
|
John C. Miles II
Age 66
|
|
Mr. Miles served as Chairman of the Board of the Company from
May 1998 until May 2005. In January 2004, he retired from
his position as Chief Executive Officer, a position which he
held since January 1, 1996. Mr. Miles served as Vice Chairman of
the Board from January 1, 1997 until becoming Chairman of the
Board in May 1998. Prior to January 1, 1996, he had been
President and Chief Operating Officer since the Merger, and
served as President and Chief Operating Officer of Old Dentsply
prior to the Merger. He is currently serving as a director of
Respironics, Inc. Mr. Miles has been a director of the Company
since the Merger and was a director of Old Dentsply commencing
January 1990.
|
|
|
|
W. Keith Smith
Age 73
|
|
Mr. Smith served as Senior Vice Chairman of Mellon Financial
Corporation and Mellon Bank, N.A., as well as a member of the
Board of Directors from 1987 until 1998. In his capacity as head
of Mellon Trust, he served as Chairman and Chief Executive
Officer of The Boston Company and Boston Safe Deposit Company,
as well as Chairman of The Dreyfus Corporation and Buck
Consultants Inc. Mr. Smith joined Mellon in 1987 as Vice
Chairman and Chief Financial Officer of Mellon Bank Corporation
and Mellon Bank, N.A., and served in that capacity until 1990.
Mr. Smith served as a Director since 1999 and, since July 2007,
as President and Chief Executive Officer of the West Penn
Allegheny Health System, until March 2008. Mr. Smith is a
Chartered Accountant and a member of the Financial Executives
Institute. He serves on the Boards of Directors of PPL
Corporation, LED Medical Diagnostics, Inc., Baytree National
Bank & Trust Co., Baytree Bancorp, River City Brass Band
Endowment, and the Greater Pittsburgh Council of the Boy Scouts
of America. Mr. Smith has served as a director of the Company
since the Merger and prior thereto served as a director of Old
Dentsply.
|
Votes
Required
The Class I directors will be elected by a plurality of the
votes of shares present and entitled to vote. Accordingly, the
four nominees for election as directors who receive the highest
number of votes actually cast will be elected. Broker non-votes
will be treated as shares that neither are capable of being
voted nor have been voted and, accordingly, will have no effect
on the outcome of the election of directors.
The Board of Directors unanimously recommends a vote FOR the
nominees for
election as Class I directors.
5
RATIFICATION
OF APPOINTMENT OF INDEPENDENT REGISTERED
PUBLIC ACCOUNTING FIRM
The Audit and Finance Committee appointed PricewaterhouseCoopers
LLP (PwC), independent registered public accounting
firm, to audit the financial statements of the Company and to
audit the Companys internal control over financial
reporting for the year ending December 31, 2008.
In connection with the audit of the Companys financial
statements, it is expected that PwC will also audit the books
and accounts of certain subsidiaries of the Company at the close
of their current fiscal years. A representative of PwC will be
present at the Annual Meeting and will have the opportunity to
make a statement, if such person desires to do so, and to
respond to appropriate questions.
Following is a summary of the fees billed to the Company by
PricewaterhouseCoopers LLP for professional services rendered
during 2007 and 2006, and are categorized in accordance with the
rules of the Securities Exchange Commission (SEC) on
auditor independence as follows (in thousands):
|
|
|
|
|
|
|
|
|
|
|
2007
|
|
|
2006
|
|
|
|
($)
|
|
|
($)
|
|
|
Audit (1)
|
|
|
2,708
|
|
|
|
2,590
|
|
Audit related (2)
|
|
|
65
|
|
|
|
75
|
|
Tax (3)
|
|
|
102
|
|
|
|
79
|
|
Other (4)
|
|
|
2
|
|
|
|
2
|
|
Total
|
|
|
2,877
|
|
|
|
2,746
|
|
|
|
|
(1) |
|
The audit fees for the years ended December 31, 2007 and
2006, respectively, were for professional services rendered for
each of the indicated fiscal years in connection with the audits
of the Companys annual consolidated financial statements
included in
Form 10-K
and review of quarterly consolidated financial statements
included in
Form 10-Qs,
or for services that are normally provided by the accountants in
connection with statutory and regulatory filings or engagements.
In addition, for the years ended December 31, 2007 and
2006, audit fees included professional services related to the
audit of the Companys internal control over financial
reporting as required by the Sarbanes-Oxley Act of 2002. |
|
(2) |
|
The audit related fees for the years ended December 31,
2007 and 2006, respectively, were for assurance and related
services that are reasonably related to the performance of the
audit or review of the Companys financial statements. Such
services include assistance in applying financial accounting and
reporting standards and certain attestation services. |
|
(3) |
|
Tax fees for the years ended December 31, 2007 and 2006,
respectively, were for audit related tax compliance in each of
the indicated fiscal years. |
|
(4) |
|
The other fees for the years ended December 31, 2007 and
2006, respectively, were for annual subscriptions to technical
references. |
The Audit and Finance Committee reviewed summaries of the
services provided by PwC and the related fees and determined
that the provision of non-audit services is compatible with
maintaining the independence of PwC.
The Audit and Finance Committee has adopted procedures for
pre-approval of services provided by PwC. Under these
procedures, all services to be provided by PwC must be
pre-approved by the Audit and Finance Committee, or can be
pre-approved by the Chairman of the Audit and Finance Committee
subject to ratification by the Committee at its next meeting.
Management makes a presentation to the Committee (or the
Chairman of the Committee, as applicable) describing the types
of services to be performed and the projected budget for such
services. Following this presentation, the Committee advises
Management of the services that are approved and the projected
level of expenditure for such services. All of the fees reported
above were approved by the Audit and Finance Committee
(Audit Committee) in accordance with their
procedures.
The proposal to ratify the appointment of PwC will be approved
by the stockholders if it receives the affirmative vote of a
majority of the shares present in person or represented by proxy
at the meeting and entitled to vote on the proposal. If there is
an abstention noted on the proxy card for this proposal, the
abstention will have the effect of a vote against the proposal,
as it is a share represented by proxy and entitled to vote.
Broker non-votes will be treated as shares not capable of being
voted on the proposal and, accordingly, will have no effect on
the outcome of voting on the proposal.
The Audit and Finance Committee and the Board of Directors
recommend a vote FOR ratification of the selection of PwC as
independent registered public accounting firm for the
Company.
6
STOCKHOLDER
PROPOSAL
We have received a stockholder proposal from Walden Asset
Management (Walden) as primary filer, whose address
is One Beacon Street, Boston, Massachusetts 02108. Walden
indicated in its proposal that it holds 265,000 shares
(approximately two tenths of a percent) of the Companys
stock and intends to introduce the following resolution at the
Annual Meeting and has furnished the following statement in
support of the proposal. There were also co-filers to the
proposal who collectively indicated they hold 40,835 shares
of the Companys stock. The names, addresses and
shareholdings of the co-filers are available upon request made
to the secretary of the Company.
SUSTAINABILITY
REPORT RESOLUTION
Whereas:
Sustainability requires balancing the needs of the present with
the needs of the future, whether these needs are considered in
ecological, economic, or societal contexts. Sustainable business
includes encouraging long lasting social well being in
communities where [companies] operate, interacting with
different stakeholders (e.g. clients, suppliers, employees,
government, local communities, and non-governmental
organizations), and responding to their specific and evolving
needs, thereby securing a long-term license to
operate, superior customer and employee loyalty, and
ultimately superior financial returns. (Dow Jones
Sustainability Group)
Mainstream institutional investment and brokerage houses are
seeking tools to understand the links between sustainability
performance and capital markets. Leading companies such as MG,
Goldman Sachs, Legg Mason, Merrill Lynch, and Morgan Stanley
collect information on companies social and environmental
practices to help make investment decisions. In addition, the
Carbon Disclosure Project, a coalition of 315 institutional
investors representing more than $40 trillion in assets, has
requested greater disclosure from companies on their climate
change programs and policies.
We believe that developing a sustainability report allows a
company to be more responsive to the global business
environment, one with finite natural resources, shifting
legislation, and changing public expectations of corporate
behavior. The reporting process helps companies to: better
integrate and gain strategic value from existing corporate
social responsibility efforts, identify gaps and opportunities,
develop company-wide communications, and structure a venue to
publicize innovative practices or respond to critiques.
Given DENTSPLYS business focus, we believe the importance
of a corporate wide analysis of opportunities and exposures in
sustainability issues is important. We believe that DENTSPLY
will benefit from understanding the risks and opportunities that
sustainability issues, such as climate change, toxins
legislation and standards for human rights, can play across its
many business lines. We ask that the company make clear to
shareholders that it is taking the necessary steps to identify,
understand, monitor, and manage sustainability issues.
RESOLVED: Shareholders request that the Board of Directors issue
a sustainability report to shareholders, at reasonable cost, and
omitting proprietary information, by September 1, 2008.
SUPPORTING
STATEMENT
The report should include the companys definition of
sustainability, as well as a company-wide review of company
policies, practices, and metrics related to long-term social and
environmental sustainability.
We recommend that DENTSPLY use the Global Reporting
Initiatives Sustainability Reporting Guidelines (the
Guidelines) to prepare the report. The Global Reporting
Initiative (www.globalreporting.org) is an international
organization developed with representatives from the business,
environmental, human rights and labor communities. The
Guidelines provide guidance on report content, including
performance on direct economic impacts, environmental, labor
practices and decent work conditions, human rights, society, and
product responsibility. The Guidelines provide a flexible
reporting system that allows the omission of content that is not
relevant to company operations. Over 800 companies use or
consult the Guidelines for sustainability reporting, including
3M, Akzo Nobel, BASF, Ingersoll-Rand, and General Electric.
7
THE BOARD
OF DIRECTORS RECOMMENDS A VOTE AGAINST THIS PROPOSAL FOR
THE FOLLOWING REASONS:
The Company recognizes the importance of social, environmental
and economic considerations in the manner in which it conducts
business and their potential impact on its economic performance.
The Company also recognizes the importance of these issues to
our stockholders and others that have business relationships
with us. The Company is committed to ethical business practices
and compliance with the law in all areas of its operations and
strives to be a good corporate citizen in the communities where
it operates. The Company takes the issues raised by the proposal
seriously but believes that conducting a special review of
social, environmental and economic performance for the purpose
of preparing an additional report to stockholders on
sustainability would be expensive, time-consuming and
unnecessary. Such a report would not add to the Companys
efforts in these areas or result in any additional benefit to
stockholders, employees or others because the Companys
current policies and practices address the concerns of the
stockholder proposal.
It should be noted that the stockholder proposal recommends the
use of the Global Reporting Initiatives (GRI)
Sustainability Reporting Guidelines to prepare the report. The
GRI Guidelines are a complex, vague and voluminous set of
metrics that would require substantial time and funds to
evaluate and apply. The proposal does not convey the burden on
human resources or the considerable expense involved in
preparing a report using the GRI Guidelines other than to note
that the sustainability report should be prepared at
reasonable cost. Information previously available on
GRIs website stated that companies that responded to a
survey conducted by GRI spent an average of more than $600,000
in preparing sustainability reports using the GRI
Guidelines with one entity spending $3 million
on its sustainability report. The Company does not believe that
stockholders would be benefited by having the Company expend
hundreds of thousands of dollars, or more, on preparing a
separate sustainability report in accordance with a costly,
complex and ambiguous set of guidelines. Instead, the Company
prefers, in the exercise of its business judgment, to prudently
allocate its limited resources and assets to the continued
development and enhancement of its business operations and the
activities described herein.
As a manufacturer of dental products in the healthcare market
the Company recognizes that its commercial success depends on
its ability to promote the health of the public and that
ultimately the achievement of the Companys business
objectives is based on the welfare of the end users of its
products, the members of the public who are treated by the
dental professionals who are our customers. Competitive
advantage and the promotion of the wellbeing of the public are
compatible objectives and are pursued by the Company in tandem.
DENTSPLY has an active and long-standing corporate social
responsibility policy. We believe that we currently integrate
and gain strategic value from our existing corporate social
responsibility initiatives. As a dental manufacturer, our first
goal is to improve the oral health of the public, including
underserved individuals, both children and adults. DENTSPLY was
instrumental in the founding of the American Fund for Dental
Health over 50 years ago, which subsequently became Oral
Health America, a vital and active non-profit organization
committed to improving the oral health of the public. The
Company continues to invest in dental charitable organizations
dedicated to providing needed dental care for children and
adults. The Company also invests in the future of dental
services and professionals through support of student research
in dental schools throughout the world. In addition, we strive
to serve as good corporate citizens improving the social,
educational and health infrastructure in the communities in
which we operate. The Company supports various non-profit and
charitable organizations with cash grants from the DENTSPLY
Foundation and encourages the Companys senior management
to donate their time through service on the boards of various
non-profit organizations. The Company also encourages its
Associates to give back to their communities by donating their
time as volunteers.
The Company believes that in addition to social considerations,
environmental considerations are also important in the conduct
of our business. Although the nature of the Companys
business is such that it is not a heavy consumer of energy
resources or raw materials, the Company has ongoing initiatives
to evaluate and improve its operating efficiencies, including
the reduction of energy usage and raw material consumption. Most
notable of these is the Companys lean manufacturing
program that is applied throughout our global manufacturing base
with an emphasis on streamlining operations, increasing
throughput per square footage of plant space, reducing material
and energy consumption, and reducing scrap materials. In
addition, the Company engages in
8
numerous recycling programs and we have various initiatives to
automate and streamline administrative functions through use of
electronic media, to reduce paper consumption in our business
units.
The Companys products and operations are subject to
extensive regulations administered by the Federal Food and Drug
Administration and similar foreign agencies. These regulations
relate to all aspects of the Companys business including
the manner in which the Company manufactures and markets its
products and operates its facilities. We are subject to periodic
inspections by agents of the FDA and other government agencies
who are responsible for ensuring that our products and practices
meet all applicable standards. Additionally, the Companys
facilities are periodically inspected by third party Notified
Bodies to allow the Companys products to be sold on a
worldwide basis.
The Company has programs to ensure compliance with FDA
regulations and all other laws applicable to our business,
including product safety, environmental and labor laws.
Specifically, although the Companys operations have
minimal environmental impacts, it maintains an environmental,
health and safety audit program to monitor its compliance with
applicable requirements. The Companys environmental
programs include, among others, hazardous and general waste
handling and management, recycling, and energy and water usage
reduction.
As a general matter, the Company does not subcontract out the
production of its products, particularly in countries where use
of child labor has been identified as occurring. Moreover, the
Company has human resources personnel responsible for various
Company operations throughout the world to ensure compliance
with applicable labor and employment laws to ensure compliance
with human rights standards.
The Companys ethical approach to business operations is
embedded in the Companys culture. The Company has adopted
a Code of Business Conduct & Ethics to promote the
appropriate and responsible conduct of its businesses throughout
the world. This Code applies to all Company personnel and all
employees receive a copy of our Code. Violation of this Code of
Conduct is basis for dismissal from the Company. The Code and
compliance activities hereunder are overseen by a corporate
compliance committee consisting of the most senior business and
legal officers of the Company. These compliance activities are
supported by the Companys commitment to sound ethical
practices and a mission statement that places
unquestionable integrity as the guiding core value
of our Company.
The Company continues to monitor and review its policies to
ensure that the principles set forth above are appropriately
implemented and to address new concerns or issues that arise by
our participation in a global marketplace whose standards
continue to evolve.
In sum, the Company believes that its existing corporate
practices including programs and activities to ensure compliance
with applicable legal requirements, existing corporate social
responsibility programs, our dedication to improving the health
and welfare of the communities in which we operate, and our
manufacturing initiatives that reduce the impact that our
operations have on the environment adequately address the
matters raised by the proposal. Therefore, conducting a special
review and preparing a sustainability report are unnecessary,
and an ineffective use of the Companys funds. The time and
expense that would be incurred would divert personnel and
resources from our business and operations, including the
sustainability activities described above, and would not be in
the best interests of our stockholders.
The proposal to request the Companys Board to prepare a
Sustainability Report will be approved if it receives the
affirmative vote of a majority of the shares present in person
or represented by proxy at the meeting and entitled to vote on
the proposal. If there is an abstention noted on the proxy card
for this proposal, the abstention will have the effect of a vote
against the proposal as it is a share represented by proxy and
entitled to vote. Broker non-votes will be treated as shares not
capable of being voted on the proposal and, accordingly, will
have no effect on the outcome of voting on the proposal.
THE BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS A VOTE AGAINST
THE PROPOSAL TO ISSUE A SUSTAINABILITY REPORT.
9
PRINCIPAL
BENEFICIAL OWNERS OF SHARES
The following table sets forth certain information with respect
to all persons or groups known by the Company to be the
beneficial owners of more than 5% of its outstanding Common
Stock as of March 17, 2008.
|
|
|
|
|
|
|
|
|
|
|
Shares Owned
|
|
|
|
Beneficially
|
|
Five Percent Stockholders
|
|
Number
|
|
|
Percent
|
|
|
Barclays Global Investors
|
|
|
9,322,394
|
(1)
|
|
|
6.3
|
|
45 Fremont Street
17th Floor
San Francisco, CA 94105
|
|
|
|
|
|
|
|
|
FMR Corp.
|
|
|
8,423,440
|
(2)
|
|
|
5.7
|
|
82 Devonshire Street
Boston, MA 02109
|
|
|
|
|
|
|
|
|
The DENTSPLY International Inc.
|
|
|
7,612,263
|
(3)
|
|
|
5.1
|
|
Employee Stock Ownership Plan Trust
c/o T.
Rowe Price
P. O. Box 17349
Baltimore, MD 21297-1349
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Based on information contained in the Amended Schedule 13G
filed by Barclays on February 5, 2008. |
|
(2) |
|
Based on information contained in the Amended Schedule 13G
filed by FMR Corp. on February 14, 2008. |
|
(3) |
|
Participants in the Company Employee Stock Ownership Plan
(ESOP) have the right to direct the trustee of the
Company ESOP as to the voting of shares allocated to such
participants accounts on all matters submitted to a vote
of the stockholders of the Company, including the election of
directors. Unallocated shares and shares as to which no
directions are received by the trustee of the Company ESOP are
voted as directed by the Company ESOP Committee, which consists
of certain employees of the Company. As of March 17, 2008,
7,612,263 of the shares held by the trust holding the assets of
the Company ESOP were allocated to participant accounts and no
shares remained unallocated. Each Company ESOP participant who
is fully vested is entitled to receive a distribution of all of
the shares of common stock allocated to his or her account as
soon as practicable after such participants employment
with the Company terminates. In general, except for participants
with fully vested balances, who have the right to diversify up
to twenty-five percent of their account balance under the Plan,
and certain participants who are age 55 or older and have
been participants in the Company ESOP for at least
10 years, participants are not entitled to sell shares
allocated to their accounts until their employment has
terminated and the shares allocated to such participants
accounts are distributed to them. |
10
STOCK
OWNERSHIP BY DIRECTORS AND EXECUTIVE OFFICERS
The following table sets forth information regarding the
beneficial ownership of the Companys Common Stock as of
March 17, 2008 held by (i) the Companys chief
executive officer, chief financial officer and the other named
executive officers, (ii), each director and nominee for director
and (iii) all directors and executive officers of the
Company as a group (based on 148,791,129 shares of Common
Stock outstanding as of such date).
|
|
|
|
|
|
|
|
|
|
|
Shares Owned
|
|
|
|
Beneficially
|
|
Stock Ownership by Executive Officers and Directors
|
|
Number
|
|
|
Percent
|
|
|
Bret W. Wise
|
|
|
442,872
|
(1)
|
|
|
*
|
|
William R. Jellison
|
|
|
367,668
|
(2)
|
|
|
*
|
|
Christopher T. Clark
|
|
|
335,666
|
(3)
|
|
|
*
|
|
James G. Mosch
|
|
|
312,909
|
(4)
|
|
|
*
|
|
Brian M. Addison
|
|
|
306,351
|
(5)
|
|
|
*
|
|
Dr. Michael C. Alfano
|
|
|
30,491
|
(6)
|
|
|
*
|
|
Eric K. Brandt
|
|
|
18,393
|
(7)
|
|
|
*
|
|
Paula H. Cholmondeley
|
|
|
43,353
|
(8)
|
|
|
*
|
|
Michael J. Coleman
|
|
|
66,563
|
(9)
|
|
|
*
|
|
Dr. Wendy L. Dixon
|
|
|
16,837
|
(10)
|
|
|
*
|
|
William F. Hecht
|
|
|
50,040
|
(11)
|
|
|
*
|
|
Leslie A. Jones
|
|
|
253,842
|
(12)
|
|
|
*
|
|
Francis J. Lunger
|
|
|
15,565
|
(13)
|
|
|
*
|
|
John C. Miles II
|
|
|
24,333
|
(14)
|
|
|
*
|
|
W. Keith Smith
|
|
|
149,170
|
(15)
|
|
|
*
|
|
All directors and executive officers as a group (17 persons)
|
|
|
2,701,974
|
(16)
|
|
|
1.8
|
|
|
|
|
* |
|
Less than 1% |
|
(1) |
|
Includes 500 shares held by Mr. Wises spouse,
2,000 shares held in an IRA account, 1,444 shares held
in a 401(k) account of Mr. Wise, 2,541 shares
allocated to the Company ESOP account of Mr. Wise,
415,977 shares which could be acquired pursuant to the
exercise of options exercisable within 60 days of
March 17, 2008 and 13,410 shares which could be
acquired pursuant to the SERP upon retirement or termination
from the Company. |
|
(2) |
|
Includes 3,000 shares held by Mr. Jellisons
family trust, 10,131 shares allocated to the Company ESOP
account of Mr. Jellison, 324,659 shares which could be
acquired pursuant to the exercise of options exercisable within
60 days of March 17, 2008 and 18,543 shares which
could be acquired pursuant to the SERP upon retirement or
termination from the Company. |
|
(3) |
|
Includes 27,890 shares allocated to the Company ESOP
account of Mr. Clark, 296,231 shares which could be
acquired pursuant to the exercise of options exercisable within
60 days of March 17, 2008 and 11,545 shares which
could be acquired pursuant to the SERP upon retirement or
termination from the Company. |
|
(4) |
|
Includes 19,971 shares allocated to the Company ESOP
account of Mr. Mosch, 283,498 shares which could be
acquired pursuant to the exercise of options exercisable within
60 days of March 17, 2008 and 9,442 shares which
could be acquired pursuant to the SERP upon retirement or
termination from the Company. |
|
(5) |
|
Includes 16,873 shares allocated to the Company ESOP
account of Mr. Addison, 274,650 shares which could be
acquired pursuant to the exercise of options exercisable within
60 days of March 17, 2008 and 11,828 shares which
could be acquired pursuant to the SERP upon retirement or
termination from the Company. |
|
(6) |
|
Consists of 24,667 shares, which could be acquired pursuant
to the exercise of options exercisable within 60 days of
March 17, 2008. |
|
(7) |
|
Consists of 18,000 shares which could be acquired pursuant
to the exercise of options exercisable within 60 days of
March 17, 2008 and 393 shares which could be acquired
pursuant to the Deferred Plan when Mr. Brandt ceases to be
a Board member. |
11
|
|
|
(8) |
|
Consists of 36,000 shares which could be acquired pursuant
to the exercise of options exercisable within 60 days of
March 17, 2008 and 7,353 shares which could be
acquired pursuant to the Deferred Plan when
Ms. Cholmondeley ceases to be a Board member. |
|
(9) |
|
Includes 12,600 shares held by Mr. Colemans
spouse, 30,000 shares which could be acquired pursuant to
exercise of options exercisable within 60 days of
March 17, 2008 and 17,963 shares which could be
acquired pursuant to the Deferred Plan when Mr. Coleman
ceases to be a Board member. |
|
(10) |
|
Consists of 13,333 shares which could be acquired pursuant
to the exercise of options exercisable within 60 days of
March 17, 2008 and 3,504 shares which could be
acquired pursuant to the Deferred Plan when Dr. Dixon
ceases to be a Board member. |
|
(11) |
|
Consists of 36,000 shares which could be acquired pursuant
to the exercise of options exercisable within 60 days of
March 17, 2008 and 14,040 shares which could be
acquired pursuant to the Deferred Plan when Mr. Hecht
ceases to be a Board member. |
|
(12) |
|
Includes 46,000 shares held by Mr. Jones spouse,
48,000 shares which could be acquired pursuant to exercise
of stock options exercisable within 60 days of
March 17, 2008 and 15,784 shares which could be
acquired pursuant to the Deferred Plan when Mr. Jones
ceases to be a Board member. |
|
(13) |
|
Includes 12,000 shares which could be acquired pursuant to
exercise of stock options exercisable within 60 days of
March 17, 2008 and 3,565 shares that could be acquired
pursuant to the Deferred Plan when Mr. Lunger ceases to be
a Board member. |
|
(14) |
|
Includes 13,333 shares which could be acquired pursuant to
exercise of stock options exercisable within 60 days of
March 17, 2008. |
|
(15) |
|
Includes 48,000 shares which could be acquired pursuant to
exercise of stock options exercisable within 60 days of
March 17, 2008 and 27,460 shares which could be
acquired pursuant to the Deferred Plan when Mr. Smith
ceases to be a Board member. |
|
(16) |
|
Includes 62,100 shares held by or for the benefit of
others, 2,000 shares held in an IRA, 1,444 shares held
in a 401(k) account, 121,024 shares allocated to
employees ESOP accounts, 2,088,809 shares which could
be acquired pursuant to the exercise of options exercisable
within 60 days of March 17, 2008, 90,061 shares
which could be acquired pursuant to the Deferred Plan when
directors cease to be Board members and 74,348 shares which
could be acquired pursuant to the SERP upon retirement or
termination of executive officers from the Company. |
SECTION 16(a)
BENEFICIAL OWNERSHIP REPORTING COMPLIANCE
Under federal securities laws, the Companys directors,
certain officers, and persons holding more than 10% of the
Common Stock of the Company are required to report, within
specified due dates, their initial ownership and any subsequent
changes in ownership of the Companys securities to the
Securities and Exchange Commission. The required reporting
periods were significantly reduced in August 2002 for most
reports to two business days. The Company is required to
describe in this proxy statement whether it has knowledge that
any person required to file such report may have failed to do so
in a timely manner. Based upon reports furnished to the Company
and written representations and information provided to the
Company by persons required to file reports, the Company
believes that during fiscal 2007, all such persons complied with
all applicable filing requirements, except that, Form 4s
were filed late for Brian Addison, Christopher Clark, William
Jellison, Rachel McKinney, James Mosch, Robert Size, Timothy
Warady and Bret Wise for a grant of Restricted Stock Units
(RSUs) in February 2007 and their annual SERP allocation in
March 2007. Also, one report was filed late for each director to
report the application of the quarterly dividend in October 2007
to their existing RSUs.
HUMAN
RESOURCES COMMITTEE REPORT ON EXECUTIVE COMPENSATION
The Human Resources Committee is comprised of three directors,
all of whom are independent under the listing standards of the
NASDAQ Stock Market, Inc. (the Listing Standards),
and operates under a written charter (a copy of the Human
Resources Committee Charter is attached to this Proxy Statement
as Appendix D). The Committee is pleased to present its
report on executive compensation. This report describes the
components of the
12
Companys executive officer compensation programs and the
basis on which compensation determinations are made with respect
to the executive officers of the Company. The Compensation
Committee has reviewed and discussed with management the
Companys Compensation Discussion and Analysis section of
this Proxy Statement. Based on such review and discussions, the
Committee has recommended to the Board of Directors that the
Compensation Discussion and Analysis be included in this Proxy
Statement. The Compensation Discussion and Analysis is
incorporated by reference into the Companys Annual Report
on
Form 10-K
for the year ended December 31, 2007.
HUMAN RESOURCES COMMITTEE
|
|
|
|
|
William F. Hecht
|
|
Michael C. Alfano
|
|
Michael J. Coleman
|
COMPENSATION
DISCUSSION AND ANALYSIS
Role
of the Human Resources Committee
The Human Resources Committee of the Board of Directors (the
Committee) administers the Companys executive
compensation program. The role of the Committee is to oversee
DENTSPLYs compensation plans and policies, administer its
equity incentive plans (including reviewing and approving equity
grants to executive officers) and annually review and approve
all compensation decisions relating to executive officers,
including those for the Chief Executive Officer
(CEO) and the other executive officers named in the
Summary Compensation Table (the Named Executive
Officers). The Committee reviews and approves, among other
things, salary increases for the Companys Named Executive
Officers, the structure of the Companys Annual Incentive
Plan, including annual performance objectives for the Named
Executive Officers; and the structure and actual grants of
awards under the Companys equity incentive programs. The
Committee reviews with the Board its decisions regarding
compensation for the CEO, and if it determines appropriate,
seeks ratification by the Board.
The Committee is assisted in its work by the Companys
Corporate Human Resources Department. In addition, with respect
to the compensation established for the Named Executive Officers
for 2007, the Committee engaged an independent compensation
consultant, Towers Perrin, to advise on matters related to CEO
and other executive compensation.
As part of the review of the CEOs compensation, the
Committee reviews and approves goals and objectives relevant to
the compensation of the Companys CEO, evaluates the
CEOs performance with respect to those goals and
objectives and determines, either as a committee or together
with the Board of Directors, the CEOs total compensation
level based on such evaluation. The Committee also reviews and
approves compensation and incentive arrangements (including
performance-based arrangements and bonus awards under the Annual
Incentive Plan) for the Companys other Named Executive
Officers (as well as such other employees of the Company as the
Committee may determine from time to time to be necessary or
desirable) and the grant of awards pursuant to the
Companys Equity Incentive Plan.
General
Compensation Philosophy and Objectives
The Committees compensation philosophy is to provide a
compensation package that is designed to satisfy the following
principal objectives:
|
|
|
|
|
to align the interests of management and employees with
corporate performance and shareholder interests. This is
accomplished by rewarding performance that is directly linked to
achievement of the Companys business plans, financial
objectives and strategic goals, as well as increases in the
Companys stock price;
|
|
|
|
to both attract and retain executives and key contributors with
the skills, capabilities and experience necessary for the
Company to achieve its business objectives. This requires that
the Companys compensation programs be competitive with
market compensation practices; and
|
|
|
|
to tie components of executives compensation to the
Companys performance by providing incentives and rewarding
individual, team and collective performance, such as through the
execution of actions that contribute to the achievement of the
Companys strategies and goals
and/or
increases in Company stock
|
13
|
|
|
|
|
price, including accomplishments within assigned functional
areas and successfully managing their respective organizations.
|
The Committee believes that compensation paid to the
Companys executive officers should be competitive with the
market, be aligned with the performance of the Company on both a
short-term and long-term basis, take into consideration
individual performance of the executive, and assist the Company
in attracting and retaining key executives critical to the
Companys long-term success. The Companys executive
compensation program balances a level of fixed compensation with
incentive compensation that varies with the performance of the
Company and the individual executive. The Companys base
pay and benefit programs for executives provide basic economic
security at a level that is consistent with the market for
executive management and competitive compensation practices. The
annual and long-term incentive compensation programs reward
performance measured against goals and standards established by
the Committee, and are designed to encourage executives to
increase shareowner value by focusing on growth in revenue and
earnings, generation of cash flow and efficient deployment of
capital, leading to increasing the Companys stock price.
Other objectives of the total compensation program are to
provide: the ability for executives to accumulate capital,
predominantly in the form of equity in the Company, in order to
align executive interests with those of the shareowners; a
competitive level of retirement income; and, in the event of
special circumstances, such as termination of employment in
connection with a change in control of the Company, special
severance protection to help ensure executive retention during
the change in control process and to ensure executive focus on
serving the Company and shareowner interests without the
distraction of possible job and income loss.
In furtherance of the philosophy and objectives discussed above,
the Committee has determined that the total compensation program
for executive officers should consist of the following
components:
|
|
|
|
|
Base Salaries
|
|
|
|
Annual Incentive awards based on achievement of annual objectives
|
|
|
|
Long-term incentive compensation
|
|
|
|
Retirement, Health & Welfare benefits
|
|
|
|
Certain post termination payments
|
Determination
of Executive Compensation
The Company focuses annually on developing a total remuneration
level for executives that is intended to be externally
competitive and meet the Companys compensation objectives.
Salary ranges, annual bonus plan targets and equity compensation
targets are developed using a total remuneration
perspective.
Generally speaking, the Company designs its compensation
programs such that there is a correlation between level of
position and degree of risk. Based on that guiding principle,
the Companys more senior executives with the highest
levels of responsibility and accountability have a higher
percentage of their total potential remuneration at risk, i.e.,
incentive and equity compensation, than do employees with lower
levels of responsibility and accountability. This means that a
higher proportion of their total potential compensation is based
upon variable incentive pay and equity compensation, than is the
case with the Companys employees with lower levels of
responsibility and accountability.
In establishing the Companys current executive
compensation policies, compensation programs and awards, the
Committee reviewed, for purposes of market comparison, the
levels of current compensation at companies of similar size as
the Company, using compensation surveys provided by Towers
Perrin. In November 2006, competitive data was developed by
Towers Perrin, using a Towers Perrin database of compensation
surveys. The database used by Towers Perrin in 2006 was
comprised of one hundred and ninety-six comparator companies
generating annual revenues of $1 billion to $3 billion
(Peer Group) and included the companies set forth in
Appendix A to this proxy statement. This data from the Peer
Group is considered by the Committee and compared with the
compensation of the Companys executive officers in
evaluating the amount and proportions of base pay, annual
incentive pay and long-term compensation, as well as the
targeted total compensation value. In reviewing
14
executive officers compensation, the Committee also
considers recommendations from the CEO regarding total
compensation for other executive officers. The Towers Perrin
report provides to the Committee historical and prospective
total compensation components for each executive officer as
compared to the Peer Group. Base pay and annual incentives are
targeted to a range around the 50th percentile, and
long-term incentives are targeted to a range around the
75th percentile of the Peer Group, subject to individual
performance and experience factors of each executive officer.
The Committee does not consider the overall wealth accumulation
or prior compensation of executives in establishing the current
level of compensation, except to the extent the prior
years compensation is considered in the comparative
analysis described above.
Determination
of Annual Base Salaries
In establishing base salaries of the Companys executives,
the Committee strives to reflect the external market value of a
particular role as well as the experiences and qualifications
that an individual brings to the role. The primary purpose of
the base salaries is to pay a fair, market competitive rate in
order to attract and retain key executives. Base salary
adjustments are generally made annually and have in the past
been awarded based on individual performance, level of
responsibilities, competitive data from the Peer Group, employee
retention efforts, the Companys overall guidelines and
annual salary budget guidelines. Base salaries are targeted to a
range around the 50th percentile of the base pay paid by
the Peer Group for a comparable role, in order to ensure that
the Company is able to compete in the market for outstanding
employees without unduly emphasizing fixed compensation.
The starting point for the Committee in establishing base
salaries and annual incentive awards is to review the total
annual cash compensation of the executive officers with the
total annual cash compensation for comparable positions in the
Peer Group. In determining the total annual cash compensation of
the executive officer, the Committee establishes a comparative
base salary and what the annual incentive awards would be at the
100% target achievement level. Once the Committee establishes
the appropriate range for base salaries relative to comparable
positions reflected in the Peer Group, the Committee adjusts the
base salary of the individual executive officer based on
consideration of several factors, including individual
performance, Company performance, the experience level of the
executive, the nature and breadth of the executives
responsibilities, and the desire to minimize the risk of losing
the services of the executive to another company. Total direct
compensation in relation to other executives, as well as prior
year individual performance and performance of the business
lines for which the executive is responsible, are also taken
into consideration in determining any adjustment. The base
salaries of the executive officers were reviewed in December
2006 in connection with the review of total compensation and
changes were made effective at the beginning of 2007. Because
target annual incentive award levels are set as a percentage of
salary, increases in salary also affect the annual cash
incentive award opportunity. At its meeting in December 2006,
the Committee approved base salaries for the named executive
officers for 2007 as follows:
Bret W. Wise, Chairman of the Board, Chief Executive Officer and
President $700,000
Christopher T. Clark, Executive Vice President and Chief
Operating Officer $450,000
William R. Jellison, Senior Vice President and Chief Financial
Officer $383,000
James G. Mosch, Senior Vice President $342,000
Brian M. Addison, Vice President, Secretary and General
Counsel $331,000
Determination
of Annual Incentive Awards
As discussed above in the section on General Compensation
Philosophy and Objectives, the Committee believes it is
important to have a portion of the executives total annual
cash compensation tied to the short-term (annual) performance of
the Company and its executives. It is intended that this
component of the total compensation of executives be competitive
with the market, but also reward executives for good performance
and reduce the targeted compensation opportunity for performance
that fails to meet the objectives established by the Committee.
The Committee believes this helps to align the compensation and
objectives of the executives with the Company and its
shareholders. Annual incentive awards are determined as a
percentage of each executives base salary. The Committee
determines the general performance measures and other terms and
conditions of awards for executives covered under the
Companys annual incentive program, and the weight
attributable to each performance goal for
15
the Named Executive Officers. For executives below the level of
the Named Executive Officers, the CEO and other executives
establish the performance objectives and weighting based on
direction provided in the Annual Incentive Plan.
The Committee annually reviews and establishes targets for
annual bonus payouts to be applicable for the performance year.
These targets are generally established in the fourth quarter of
the year preceding or at the beginning of the performance year.
In establishing the target payouts, the Committee evaluates the
compensation levels in the Peer Group. The Committee establishes
performance targets for the executive officers, which if
achieved at the 100% level, would result in annual bonuses that,
in combination with base salary, are competitive in the
50th percentile range with the total annual compensation of
comparable positions in the Peer Group. If the Company exceeds
the targets established by the Committee, the executives will be
rewarded with higher annual bonuses and if the Company falls
below the targets, the executives bonuses will be reduced
below the 100% target level. The general principle in setting
targets and measuring performance is that management is
responsible and accountable for the financial results of the
Company as measured based on United States (U.S.)
Generally Accepted Accounting Principles (GAAP)
consistently applied. The annual incentive plan provides that
the Committee may adjust the GAAP results to address unique or
significant events, such as the impact of merger and acquisition
activity, charges related to settlement of litigation,
unbudgeted restructuring expenses or gains, interest carrying
costs related to unbudgeted share repurchases, and the impact of
significant or non- recurring unbudgeted one-time gains or
losses, that were not considered in the targets set for the
year, are not reflective of current operations, or benefit
future periods.
As noted earlier, the Committee believes that employees in
higher ranks should have a higher proportion of their total
compensation delivered through
pay-for-performance
cash incentives; as a result, their total annual compensation
will be more significantly correlated, both upward and downward,
to the Companys performance. The variability of the cash
compensation of the Companys executives is closely linked
to annual financial results of the Company, delivering
lower-than-market
total cash compensation in times of poor financial performance
and higher total cash compensation when the Company performs
well. Consistent with this principle, for 2007, the bonus
targets for the named Executive Officers ranged from 50 to 100%
of base salary depending on the executives position, as
set forth below.
Bret W. Wise, Chairman, Chief Executive Officer and
President 100%
Christopher T. Clark, Executive Vice President and Chief
Operating Officer 75%
William R. Jellison, Senior Vice President and Chief Financial
Officer 55%
James G. Mosch, Senior Vice President 55%
Brian M. Addison, Vice President, Secretary and General
Counsel 50%
As noted above, the actual annual incentive awards are based on
an executives performance against objectives established
by the Committee. Generally, the Committee expects awards, in
the aggregate, to range from 90% to 110% of target. Awards may
range from no award being earned to 200% of target, although
attainment at the maximum award level is not expected. Awards,
for the positions of the Named Executive Officers over the last
three years have ranged from 93.6% to 145.5% of target. The key
performance measures for the Named Executive Officers are
targets for the Companys net income and internal sales
growth. In the case of operating executives who have
responsibility for certain businesses, in addition to the
targets for the Companys income and sales growth, a
portion of their annual target is comprised of the operating
income and internal sales growth of those businesses. The
targets for net income and internal sales growth are evaluated
in conjunction so that minimal levels of achievement must be met
on both targets in order for any incentive award to be paid. The
Committee establishes objectives for net income and internal
sales growth which it believes is challenging but fair and
consistent with the executive compensation objectives described
above. If the objectives are met the Company will produce better
than market results which should translate into greater
shareholder returns. The targets for 2007 at 100% for the Named
Executive Officers, other than Mr. Mosch, who has direct
operating segment responsibility, were internal sales growth of
5% and corporate net income of $244.5 million. 50% of
Mr. Moschs objectives were based on the same
objectives as the other Named Executive Officers and the other
50% was based on the sales growth and income from operations of
the operating segment for which Mr. Mosch had
responsibility. The Company believes it would be
16
competitively harmful to disclose the operating segment
objectives as that would enable competitors to identify what the
financial targets and business strategies are for certain
specific operating businesses. The targets for the operating
segments are set based on the projected budgets for the
operating businesses and are meant to be challenging and which,
if met, would result in the operating business outperforming its
competition in the market.
At its February 2008 meeting, the Committee reviewed the
performance of the Company and its executives with respect to
objectives to determine whether the Named Executive Officers had
met or exceeded the 2007 performance goals. Annual cash
incentive awards are determined by multiplying the results for
each performance objective by the target award opportunity for
each Named Executive Officer as described above, and then
multiplied by the base salary as of December 31, 2007, the
end of the performance period.
The target net income used for annual incentive objective
purposes is corporate reported net income, net of specific items
as described above. The items that were excluded from reported
net income for 2007 were unbudgeted restructuring and other
costs, the impact of unbudgeted acquisitions, interest carrying
costs on unbudgeted share repurchases, and the favorable impact
of the change in the corporate tax rate in Germany.
Based on the Committees assessment of the performance of
the Named Executive Officers and the Company, the Named
Executive Officers were paid bonuses at the percent of target as
set forth below:
Bret W. Wise, Chairman, Chief Executive Officer and
President 145.5%
Christopher T. Clark, Executive Vice President and Chief
Operating Officer 145.5%
William R. Jellison, Senior Vice President and Chief Financial
Officer 145.5%
James G. Mosch, Senior Vice President 160.4%
Brian M. Addison, Vice President, Secretary and General
Counsel 145.5%
Long-Term
Incentive Compensation
The third principal component in total compensation for the
Companys executives is the award of stock options and
restricted stock units (RSUs) under the
Companys Equity Incentive Plan.
The Committee believes that long-term incentive compensation
serves an essential purpose in attracting and retaining senior
executives and providing them long-term incentives to maximize
shareholder value. We also believe that long-term incentive
awards align the interests of the executive officers with those
of our shareowners. Long-term incentive awards for executive
officers are made generally annually, as part of the total
remuneration approach to executive compensation, under the
shareholder-approved Amended and Restated Dentsply Equity
Incentive Plan. The long-term incentive program is designed to
reward mid- and long-term performance and is currently comprised
of two components:
|
|
|
|
|
Stock option awards designed to reward stock price
growth; and
|
|
|
|
RSU awards based on performance on operational, financial and
strategic goals, as well as stock price growth.
|
A stock option becomes valuable only if DENTSPLYs stock
price increases above the option exercise price and the holder
of the option remains employed for the period required for the
option to vest. This provides an incentive for an option holder
to remain employed by DENTSPLY and to maximize shareholder
value. The Committee believes that equity-based compensation
ensures that the Companys executive officers have a
continuing stake in the long-term success of the Company and is
most closely aligned with the interest of shareholders. For this
reason, the Committee has placed more emphasis and weight on the
long-term equity incentive portion of the total compensation of
executives, targeting the equity incentive compensation at a
range around the 75th percentile of the Peer Group.
Historically, the Companys equity incentive has been
comprised of stock options which are granted at the Board
meeting in December of each year as well as to newly hired
executives at the Committee meeting which follows the
executives employment date. Stock options are granted at
the closing price on the day of the grant and accordingly, will
have value only if the market price of the Companys common
stock increases after the grant date.
17
As a result, stock option awards are designed to reward
executives for increases in the Companys stock price.
Stock option grants become exercisable over three
years one-third at the end of each year following
grant and are exercisable for ten years from the
grant date, subject to earlier expiration in the event of
termination of employment or retirement. Under the terms of the
Companys Equity Incentive Plan, RSUs and unvested stock
options are forfeited if the executive voluntarily leaves prior
to a qualified retirement.
During 2006, the Committee performed a comprehensive review of
the use and value of the Companys Equity Incentive Program
with respect to executive officer compensation programs. As a
result of this review, the Committee decided to utilize,
beginning in 2007, RSUs as part of the Companys equity
incentive program, in addition to stock options. The Committee
believes that the use of RSUs as part of the Companys
equity compensation program is more consistent with current
market practices, provides a greater opportunity for executives
to build share ownership in the Company, provides an incentive
for executives to remain with the Company and provides an equity
vehicle that allows DENTSPLY to attract, motivate and retain the
employee talent considered critical for achieving the
Companys goals.
Determination
of Stock Option and RSU Grants
Guidelines for the size and type of awards are developed based
upon, among other factors, shares available for grant under the
Equity Incentive Plan, the executives position in the
Company, his or her contributions to the Companys
objectives and total compensation, as compared to the Peer
Group. Larger equity awards are made to more senior executives
so that a larger portion of their total potential compensation
will be variable and will increase upon shareholder value
creation. In determining the size of equity incentive grants to
executive officers, the Committee targets a range around the
75th percentile of the Peer Group for persons holding
comparable positions. The Committee then takes into
consideration the Companys performance against its
business and financial objectives and its strategic plan, and
individual performance, as well as the allocation of overall
share usage attributed to executive officers. With respect to
the number of RSUs granted, the Committee focuses, in
particular, on the performance of the Company over the prior
three years, primarily based on performance of executives
relative to objectives under the Annual Incentive Plan. Once the
RSU grant target for each executive is established it may be
adjusted up or down based on performance of the Company against
the objectives under the Annual Incentive Plan for the prior
three years, and the Companys progress toward certain
strategic objectives.
For stock option grants in December 2007 and grants of RSUs in
February 2007, 70% of the expected value target established by
the Committee was converted to an estimated number of stock
options, and the remaining 30% of value was converted to RSUs.
The split between stock options and RSUs was based both on
comparisons to the market and the overall risk/reward tradeoff.
With respect to the RSUs, the Committee considered the
performance of the Company against the annual objectives for the
past three years and progress by the Company against strategic
objectives. Based on this review, the Committee determined that
RSU grants in February 2007 should be made at 100% of targeted
levels. In this determination, the Committee weighed heavily the
progress made in 2007 against both established earnings and
sales targets and strategic objectives.
While equity awards under the Equity Incentive Plan generally
involve no immediate cash cost, the Company does recognize
expense for such awards in accordance with Statement of
Financial Accounting Standards (SFAS)
No. 123(R), Share-Based Payment
(SFAS No. 123(R)).
Equity
Grant Practices
The Committee reviewed the Companys practices for equity
incentive grants. The grant date utilized for annual and other
grants is always on the date the Committee or the Board approves
the grants. Stock options are granted with an exercise price
equal to the closing price on the day of the grant and with RSUs
the recipient is granted a right to a specified number of shares.
18
Post-Termination
Arrangements
Termination
of Employment
The Company has entered employment agreements with all of the
Named Executive Officers. Each of these employment agreements
provides that, upon termination of such individuals
employment with the Company as a result of the employees
death, the Company is obligated to pay the employees
estate the then current base compensation of the employee for a
period of one year following the date of the employees
death, together with the employees pro rata share of any
incentive or bonus payments for the period prior to the
employees death in the year of such death. Each of the
employment agreements also provides that, in the event that the
employees employment is terminated by the Company other
than in a change of control of the Company (as defined in the
agreements) without cause, or by the employee with good reason,
(i) the Company will be obligated to pay the employee, for
a period of two years subsequent to termination of employment,
all compensation at the base salary rate immediately preceding
the termination, and (ii) the employee will be entitled to
receive the benefits that they would have accrued during the
two-year period following termination under employee benefit
plans, programs or other arrangements of the Company or any of
its affiliates in which the employee participated before their
termination.
The amounts that each Named Executive Officer would receive in
the event of a termination described above is set forth in the
Potential Payment Upon Termination or Change in Control tables
below.
Termination
following
Change-in-Control
The Committee believes executive officers, including all the
Named Executive Officers, who are terminated or elect to resign
for good reason (as defined in the employment
agreements) in connection with a change in control (as defined
in the employment agreements) of the Company should be provided
separation benefits. These benefits are intended to ensure that
executives focus on serving the Company and shareholder
interests during a change in control transaction or activity
without the distraction of possible job and income loss.
The Companys
change-in-control
benefits are consistent with the practices of companies with
whom DENTSPLY competes for talent, and are intended to assist in
retaining executives and recruiting new executives to the
Company. As of the close of a transaction that results in a
change in control of DENTSPLY, all outstanding equity grants
awarded as part of the Companys equity incentive
compensation program become available to executives, that is,
restrictions on all outstanding restricted stock units lapse and
all non-exercisable stock options become exercisable. In the
event that a termination of employment is made by the Company
without cause or by the employee with good reason within a
period of two (2) years after a change in control of the
Company, the Company is required to pay to the Named Executive
Officers, within five days after the employees termination
(subject to the requirements of Section 409A(a)(2)(B) of
the Internal Revenue Code), the benefits described in the
Potential Payment Upon Termination or Change in Control tables
below.
Retirement
and Other Benefits
The Company also maintains standard benefits that are consistent
with those offered by other major corporations and are generally
available to all of the Companys full time employees
(subject to meeting basic eligibility requirements).
DENTSPLY offers retirement benefits to its U.S. employees
through tax-qualified plans, including an employee and
employer-funded 401(k) Savings Plan and a discretionary
company-funded Employee Stock Ownership Plan (ESOP).
The Committee allows for the participation of the executive
officers in these plans, and the terms governing the retirement
benefits under these plans for the executive officers are the
same as those available for other eligible employees in the
U.S. Similarly situated employees, including
DENTSPLYs executive officers, may have materially
different account balances because of a combination of factors:
the number of years that the person has participated in the
plan; the amount of money contributed, and the investments
chosen by the participant with regard to those plans providing
for participant investment direction. These plans do not involve
any guaranteed minimum returns or above-market returns as the
investment returns are dependent upon actual investment results.
Employees direct their own investments in the 401(k) Savings
Plan. The ESOP is a defined
19
contribution plan designed to allow employees, including
executive officers, to accumulate retirement accounts through
ownership of Company stock, and to allow DENTSPLY to make
contributions or allocations to those funds.
DENTSPLYs healthcare, insurance, and other welfare and
employee-benefit programs are the same for all eligible
employees, including the Named Executive Officers. DENTSPLY
shares the cost of health and welfare benefits with its
employees, a cost that is dependent on the level of benefits
coverage that each employee elects. The Company also provides
other benefits such as medical, dental and life insurance to
each Named Executive Officer, in a similar fashion to those
provided to all other
U.S.-based
DENTSPLY employees.
The Company maintains a very limited number of benefit programs
that are only available to the Named Executive Officers and
other senior employees qualifying for eligibility based on
salary grade level. Such benefits include a Supplemental
Executive Retirement Plan (SERP) and the Dentsply
Supplemental Savings Plan (DSSP). The purpose of the
SERP is to provide additional retirement benefits for a limited
group of management employees, including the Named Executive
Officers, whom the Board concluded were not receiving
competitive retirement benefits. The Committee annually approves
participants in the SERP. Contributions equal to 11.7% of total
annual compensation, reduced by Company contributions to the
ESOP and 401(k) plans, are allocated to the participants
accounts. No actual benefits are put aside for participants in
the SERP and the participants are general creditors of the
Company for payment of the benefits upon retirement or
termination from the Company. Participants can elect to have
these benefits administered as savings with interest or stock
unit accounts, with stock units being distributed in the form of
common stock at the time of distribution. Upon retirement or
termination for any reason, participants in the SERP are paid
the benefits in their account based on an earlier distribution
election.
Effective January 1, 2008, the Company adopted the DSSP.
This is a deferred compensation plan that allows management
employees of the Company, including the Named Executive
Officers, to defer a portion of their base salary and annual
incentive bonus for payment at a future time, as elected by the
participant. Deferred amounts are not funded by the Company but
are a general obligation of the Company to administer and pay as
set forth in the DSSP. The Plan is administered by T. Rowe
Price, the Administrator of the Companys retirement plans,
and participants have the right to elect investment options for
the deferred funds, which are tracked by the Administrator.
Stock
Ownership Guidelines
Because the Committee believes in further linking the interests
of management and the shareholders, the Company maintains stock
ownership guidelines for its executives. The guidelines specify
the number of shares that DENTSPLYs executive management
should accumulate and hold within six (6) years of the date
of appointment to the executive position. Stock
ownership is defined to include stock owned by the officer
directly, stock owned indirectly through the Companys
retirement Plans, and stock awarded pursuant to the equity
incentive program, other than stock options. Under the current
guideline established by the Committee, executives are required
to own Company common stock equal in value to a multiple of
their base salary, as set forth below:
|
|
|
|
|
Chief Executive Officer
|
|
|
5X
|
|
Chief Operating Officer
|
|
|
3X
|
|
Senior Vice Presidents
|
|
|
2X
|
|
Vice Presidents
|
|
|
1X
|
|
All Named Executive Officers in their positions for at least six
(6) years were in compliance with the Stock Ownership
Guidelines as of the end of 2007.
20
Tax
Deductibility of Executive Compensation
Section 162(m) of the Internal Revenue Code of 1986, as
amended (the Tax Code), places a limit of $1,000,000
on the amount of compensation that the Company may deduct in any
one year with respect to the Named Executive Officers. There is
an exception to the $1,000,000 limitation for performance-based
compensation meeting certain requirements. Stock option
incentive awards generally are performance-based compensation
meeting those requirements, and, as such, are believed to be
fully deductible. The Committee generally seeks ways to limit
the impact of Section 162(m), however, the Committee
believes that the tax deduction limitation should not compromise
our ability to establish and implement incentive programs that
support the compensation objectives discussed above.
Accordingly, achieving these objectives and maintaining required
flexibility in this regard may result in compensation that is
not deductible for federal income tax purposes. To maintain
flexibility in compensating executive officers in a manner
designed to promote varying corporate goals, the Committee has
not adopted a policy requiring all compensation to be
deductible. The Committee has established a performance goal for
the Chief Executive Officer, Chief Operating Officer and Chief
Financial Officer for the vesting of their RSUs granted in 2007,
requiring the Company to be profitable over the three year
vesting period, consistent with the performance based
requirements established by 162(m).
21
EXECUTIVE
COMPENSATION TABLES
Summary
Compensation
The following table sets forth the compensation earned by the
named executive officers for the fiscal year ended
December 31, 2007. The named executive officers are the
Companys chief executive officer, chief financial officer,
and three other most highly compensated executive officers
ranked in the table below by their total compensation.
Summary
Compensation Table
For Fiscal Year End December 31, 2007
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
in Pension
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Value and
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nonqualified
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-Equity
|
|
Deferred
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock
|
|
Option
|
|
Incentive Plan
|
|
Compensation
|
|
All Other
|
|
|
|
|
|
|
Salary
|
|
Bonus
|
|
Awards
|
|
Awards
|
|
Compensation
|
|
Earnings
|
|
Compensation
|
|
Total
|
Name and Principle Position(1)
|
|
Year
|
|
($)
|
|
($)
|
|
($)(7)
|
|
($)(8)
|
|
($)(9)
|
|
($)
|
|
($)(10)
|
|
($)
|
|
Bret W. Wise
|
|
|
2007
|
|
|
|
700,000
|
|
|
|
|
|
|
|
895,116
|
|
|
|
1,686,574
|
|
|
|
1,018,200
|
|
|
|
|
|
|
|
115,136
|
|
|
|
4,415,026
|
|
Chairman of the Board, Chief Executive Officer and President (2)
|
|
|
2006
|
|
|
|
477,000
|
|
|
|
|
|
|
|
|
|
|
|
1,526,909
|
|
|
|
334,900
|
|
|
|
|
|
|
|
84,179
|
|
|
|
2,422,988
|
|
William R. Jellison
|
|
|
2007
|
|
|
|
383,000
|
|
|
|
|
|
|
|
192,250
|
|
|
|
389,209
|
|
|
|
306,400
|
|
|
|
|
|
|
|
61,024
|
|
|
|
1,331,883
|
|
Senior Vice President and Chief Financial Officer (3)
|
|
|
2006
|
|
|
|
368,000
|
|
|
|
|
|
|
|
|
|
|
|
328,742
|
|
|
|
189,400
|
|
|
|
|
|
|
|
78,005
|
|
|
|
964,147
|
|
Christopher T. Clark
|
|
|
2007
|
|
|
|
450,000
|
|
|
|
|
|
|
|
321,442
|
|
|
|
680,829
|
|
|
|
490,900
|
|
|
|
|
|
|
|
70,594
|
|
|
|
2,013,766
|
|
President and Chief Operating Officer (4)
|
|
|
2006
|
|
|
|
330,000
|
|
|
|
|
|
|
|
|
|
|
|
549,966
|
|
|
|
204,200
|
|
|
|
|
|
|
|
55,818
|
|
|
|
1,139,984
|
|
James G. Mosch
|
|
|
2007
|
|
|
|
342,000
|
|
|
|
|
|
|
|
149,186
|
|
|
|
350,174
|
|
|
|
301,700
|
|
|
|
|
|
|
|
49,488
|
|
|
|
1,192,547
|
|
Senior Vice President (5)
|
|
|
2006
|
|
|
|
297,000
|
|
|
|
|
|
|
|
|
|
|
|
254,485
|
|
|
|
131,800
|
|
|
|
|
|
|
|
46,563
|
|
|
|
729,848
|
|
Brian M. Addison
|
|
|
2007
|
|
|
|
331,000
|
|
|
|
|
|
|
|
126,116
|
|
|
|
252,584
|
|
|
|
240,700
|
|
|
|
|
|
|
|
50,190
|
|
|
|
1,000,590
|
|
Vice President, Secretary and General Counsel (6)
|
|
|
2006
|
|
|
|
318,000
|
|
|
|
|
|
|
|
|
|
|
|
215,036
|
|
|
|
148,800
|
|
|
|
|
|
|
|
53,829
|
|
|
|
735,665
|
|
|
|
|
(1) |
|
Principal positions are the positions held during 2007. |
|
(2) |
|
Mr. Wise was appointed President and Chief Operating
Officer effective January 1, 2006. Mr. Wise was named
Chairman of the Board, Chief Executive Officer and President of
the Company effective January 1, 2007. |
|
(3) |
|
Mr. Jellison served as Senior Vice President, Chief
Financial Officer from April 20, 1998 to October 12,
2002, then served as a Senior Vice President in charge of an
operating unit and was reappointed Senior Vice President and
Chief Financial Officer January 10, 2005. |
|
(4) |
|
Mr. Clark was appointed Senior Vice President effective
November 1, 2002. Mr. Clark was named Executive Vice
President and Chief Operating Officer of the Company effective
January 1, 2007. |
|
(5) |
|
Mr. Mosch was appointed Senior Vice President effective
November 1, 2002. |
|
(6) |
|
Mr. Addison was appointed Vice President, Secretary and
General Counsel effective January 1, 1998. |
|
(7) |
|
Represents the compensation costs of RSUs granted in 2007 for
financial statement reporting purposes in accordance with
SFAS 123(R). Information regarding the calculation of these
amounts for the fiscal year ended December 31, 2007 is
included in Note 11 to the Companys Consolidated
Financial Statements. |
|
(8) |
|
Represents the compensation costs of stock options recognized in
2007 and 2006 for financial statement reporting purposes in
accordance with SFAS 123(R), using the Black-Scholes option
pricing model. Assumptions used in the calculation of these
amounts for fiscal years ended December 31, 2007 and 2006
are included in Note 11 to the Companys Consolidated
Financial Statements. |
|
(9) |
|
Amounts shown for 2007 and 2006, respectively, represent
Incentive Compensation Plan earnings for services provided in
2007 that were paid in cash in 2008 and earnings for services
provided in 2006 that were paid in cash in 2007. There were no
earnings on outstanding non-equity incentive plan awards. |
22
|
|
|
(10) |
|
Amounts shown are described in the All Other Compensation table
that follows. |
Refer to the Compensation Discussion and Analysis section for a
complete description of the components of compensation, along
with a description of the material terms and conditions of each
component.
For the named executive officers, salary compensation as a
percentage of total compensation are as follows:
Mr. Wise 16.0%, Mr. Jellison
28.7%, Mr. Clark 22.5%,
Mr. Mosch 28.8%, and
Mr. Addison 33.0%
Grants
of Plan-Based Awards
The following table reflects the terms of compensation
plan-based awards granted to Named Executive Officers in 2007.
2007
Grants of Plan-Based Awards
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Grant
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
All Other
|
|
All Other
|
|
Exercise
|
|
Date
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock
|
|
Option
|
|
or
|
|
Fair
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Awards:
|
|
Awards:
|
|
Base
|
|
Value of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of
|
|
Number of
|
|
Price of
|
|
Stock
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Securities
|
|
Securities
|
|
Option
|
|
and
|
|
|
|
|
Estimated Future Payouts Under Non-Equity Incentive Plan
Awards(1)
|
|
Estimated Future Payouts Under Equity Incentive Plan
Awards(9)
|
|
Underlying
|
|
Underlying
|
|
Awards
|
|
Option
|
|
|
Grant
|
|
Threshold
|
|
Target
|
|
Maximum
|
|
Threshold
|
|
Target
|
|
Maximum
|
|
Options
|
|
Options
|
|
($/Share)
|
|
Awards
|
Name of Executive Officer
|
|
Date
|
|
($)
|
|
($)
|
|
($)
|
|
(#)
|
|
(#)
|
|
(#)
|
|
(#)(9)
|
|
(#)(7)
|
|
(8)
|
|
($)(10)
|
|
Bret W. Wise
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Incentive Compensation (2)
|
|
|
|
|
|
|
|
|
|
|
700,000
|
|
|
|
1,400,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
RSUs
|
|
|
2/5/2007
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0
|
|
|
|
29,100
|
|
|
|
29,100
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
895,116
|
|
Options
|
|
|
12/10/2007
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
146,900
|
|
|
|
45.15
|
|
|
|
1,686,574
|
|
William R. Jellison
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Incentive Compensation (3)
|
|
|
|
|
|
|
|
|
|
|
210,650
|
|
|
|
421,300
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
RSUs
|
|
|
2/5/2007
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0
|
|
|
|
6,250
|
|
|
|
6,250
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
192,250
|
|
Options
|
|
|
12/10/2007
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
33,900
|
|
|
|
45.15
|
|
|
|
389,209
|
|
Christopher T. Clark
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Incentive Compensation (4)
|
|
|
|
|
|
|
|
|
|
|
337,500
|
|
|
|
675,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
RSUs
|
|
|
2/5/2007
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0
|
|
|
|
10,450
|
|
|
|
10,450
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
321,442
|
|
Options
|
|
|
12/10/2007
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
59,300
|
|
|
|
45.15
|
|
|
|
680,829
|
|
James G. Mosch
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Incentive Compensation (5)
|
|
|
|
|
|
|
|
|
|
|
188,100
|
|
|
|
376,200
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
RSUs
|
|
|
2/5/2007
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4,850
|
|
|
|
|
|
|
|
|
|
|
|
149,186
|
|
Options
|
|
|
12/10/2007
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
30,500
|
|
|
|
45.15
|
|
|
|
350,174
|
|
Brian M. Addison
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Incentive Compensation (6)
|
|
|
|
|
|
|
|
|
|
|
165,500
|
|
|
|
331,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
RSUs
|
|
|
2/5/2007
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4,100
|
|
|
|
|
|
|
|
|
|
|
|
126,116
|
|
Options
|
|
|
12/10/2007
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
22,000
|
|
|
|
45.15
|
|
|
|
252,584
|
|
|
|
|
(1) |
|
Amounts shown represent threshold, target and maximum amounts
for the 2007 Annual Incentive Award compensation plans. The
Human Resources Committee established the targets on
December 12, 2006. Target amounts would be achieved if
budgeted net income and sales growth were achieved. For
instance, Mr. Wises target was 100% of his salary
($700,000) if the Company achieved budgeted net income and
budgeted sales growth in 2007. Under the plan, the threshold is
30% of the target amount if minimum sales growth of 2.5% and at
least 90% of budgeted net income is met. Maximum amounts
represent the greatest amounts that could be earned under the
Incentive Compensation Plan. The maximum non-equity incentive
compensation is earned if sales growth meets or exceeds 7.5% and
net income is 110% of budget or more. Mr. Wises
maximum was his base salary ($700,000) multiplied by his
incentive compensation percentage (100%) multiplied by 200%.
Payments of Annual Incentive Award compensation for 2007 are
shown in the Non-Equity Incentive Plan Compensation column of
the 2007 Summary Compensation Table. Refer to the Compensation
Discussion and Analysis for a description of the criteria for
payment of Annual Incentive Awards. |
|
(2) |
|
Mr. Wises incentive compensation target was
calculated at 100% of his base salary. |
|
(3) |
|
Mr. Jellisons incentive compensation target was
calculated at 55% of his base salary. |
|
(4) |
|
Mr. Clarks incentive compensation target was
calculated at 75% of his base salary. |
|
(5) |
|
Mr. Moschs incentive compensation target was
calculated at 55% of his base salary. |
23
|
|
|
(6) |
|
Mr. Addisons incentive compensation target was
calculated at 50% of his base salary |
|
(7) |
|
Amounts shown are the number of stock options granted to the
named officers in 2007. Refer to the Compensation Discussion and
Analysis for a description of the terms of and criteria for
making these awards. |
|
(8) |
|
Price reflects the closing price of DENTSPLY International
common stock on the date the Board of Directors approved the
grant. |
|
(9) |
|
These RSUs are credited with dividends when paid in the form of
fractional shares, and upon vesting are included in the stock
distributed to recipients. |
|
(10) |
|
The assumptions used in calculating the fair values of stock
options and RSUs are included in Note 11 to the
Companys Consolidated Financial Statements. |
The grant date of stock and option awards is always on the date
the Human Resources Committee or the Board of Directors approves
the grants. Stock options are granted with an exercise price
equal to the closing price on the day of the grant.
Outstanding
Equity Awards at Year End
The following table reflects the number and terms of stock
option awards and stock awards outstanding as of
December 31, 2007 for the named executive officers.
Outstanding
Equity Awards at Fiscal Year End
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Option Awards
|
|
|
Stock Awards
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Incentive
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity
|
|
|
Plan
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Incentive
|
|
|
Awards:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Plan
|
|
|
Market or
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Awards:
|
|
|
Payout
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of
|
|
|
Value of
|
|
|
|
|
|
|
|
|
|
Equity
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unearned
|
|
|
Unearned
|
|
|
|
|
|
|
|
|
|
Incentive
|
|
|
|
|
|
|
|
|
|
|
|
Market
|
|
|
Shares,
|
|
|
Shares,
|
|
|
|
|
|
|
Number of
|
|
|
Plan Awards:
|
|
|
|
|
|
|
|
|
|
|
|
Value of
|
|
|
Units or
|
|
|
Units or
|
|
|
|
Number of
|
|
|
Securities
|
|
|
Number of
|
|
|
|
|
|
|
|
|
Number of
|
|
|
Shares or
|
|
|
Other
|
|
|
Other
|
|
|
|
Securities
|
|
|
Underlying
|
|
|
Securities
|
|
|
|
|
|
|
|
|
Shares or
|
|
|
Units of
|
|
|
Rights
|
|
|
Rights
|
|
|
|
Underlying
|
|
|
Unexercised
|
|
|
Underlying
|
|
|
Option
|
|
|
|
|
|
Units of Stock
|
|
|
Stock
|
|
|
That
|
|
|
That
|
|
|
|
Unexercised
|
|
|
Options
|
|
|
Unexercised
|
|
|
Exercise
|
|
|
Option
|
|
|
That
|
|
|
That
|
|
|
Have Not
|
|
|
Have Not
|
|
|
|
Options
|
|
|
(Unexercisable)
|
|
|
Unearned
|
|
|
Price
|
|
|
Expiration
|
|
|
Have Not
|
|
|
Have Not
|
|
|
Vested
|
|
|
Vested
|
|
|
|
(Exercisable)
|
|
|
(#)
|
|
|
Options
|
|
|
($)
|
|
|
Date
|
|
|
Vested
|
|
|
Vested
|
|
|
(#)
|
|
|
($)
|
|
Name
|
|
(#)
|
|
|
(1)
|
|
|
(#)
|
|
|
(2)
|
|
|
(3)
|
|
|
(#)
|
|
|
($)
|
|
|
(4)
|
|
|
(5)
|
|
|
Bret W. Wise
|
|
|
109,000
|
|
|
|
|
|
|
|
|
|
|
|
18.49
|
|
|
|
Dec 11,2012
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
59,600
|
|
|
|
|
|
|
|
|
|
|
|
22.14
|
|
|
|
Dec 15,2013
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
60,854
|
|
|
|
|
|
|
|
|
|
|
|
27.45
|
|
|
|
Dec 13,2014
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
120,723
|
|
|
|
60,361
|
|
|
|
|
|
|
|
27.74
|
|
|
|
Dec 13,2015
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
65,800
|
|
|
|
131,600
|
|
|
|
|
|
|
|
31.36
|
|
|
|
Dec 12,2016
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
146,900
|
|
|
|
|
|
|
|
45.15
|
|
|
|
Dec 10,2017
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
29,100
|
|
|
|
895,116
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
415,977
|
|
|
|
338,861
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
29,100
|
|
|
|
895,116
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
William R. Jellison
|
|
|
78,300
|
|
|
|
|
|
|
|
|
|
|
|
15.58
|
|
|
|
Dec 12,2011
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
69,000
|
|
|
|
|
|
|
|
|
|
|
|
18.49
|
|
|
|
Dec 11,2012
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
59,600
|
|
|
|
|
|
|
|
|
|
|
|
22.14
|
|
|
|
Dec 15,2013
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
41,836
|
|
|
|
|
|
|
|
|
|
|
|
27.45
|
|
|
|
Dec 13,2014
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
13,467
|
|
|
|
6,733
|
|
|
|
|
|
|
|
26.69
|
|
|
|
Mar 22,2015
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
48,289
|
|
|
|
24,145
|
|
|
|
|
|
|
|
27.74
|
|
|
|
Dec 13,2015
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
14,167
|
|
|
|
28,333
|
|
|
|
|
|
|
|
31.36
|
|
|
|
Dec 12,2016
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
33,900
|
|
|
|
|
|
|
|
45.15
|
|
|
|
Dec 10,2017
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6,250
|
|
|
|
192,250
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
324,659
|
|
|
|
93,111
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6,250
|
|
|
|
192,250
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
24
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Option Awards
|
|
|
Stock Awards
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Incentive
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity
|
|
|
Plan
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Incentive
|
|
|
Awards:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Plan
|
|
|
Market or
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Awards:
|
|
|
Payout
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of
|
|
|
Value of
|
|
|
|
|
|
|
|
|
|
Equity
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unearned
|
|
|
Unearned
|
|
|
|
|
|
|
|
|
|
Incentive
|
|
|
|
|
|
|
|
|
|
|
|
Market
|
|
|
Shares,
|
|
|
Shares,
|
|
|
|
|
|
|
Number of
|
|
|
Plan Awards:
|
|
|
|
|
|
|
|
|
|
|
|
Value of
|
|
|
Units or
|
|
|
Units or
|
|
|
|
Number of
|
|
|
Securities
|
|
|
Number of
|
|
|
|
|
|
|
|
|
Number of
|
|
|
Shares or
|
|
|
Other
|
|
|
Other
|
|
|
|
Securities
|
|
|
Underlying
|
|
|
Securities
|
|
|
|
|
|
|
|
|
Shares or
|
|
|
Units of
|
|
|
Rights
|
|
|
Rights
|
|
|
|
Underlying
|
|
|
Unexercised
|
|
|
Underlying
|
|
|
Option
|
|
|
|
|
|
Units of Stock
|
|
|
Stock
|
|
|
That
|
|
|
That
|
|
|
|
Unexercised
|
|
|
Options
|
|
|
Unexercised
|
|
|
Exercise
|
|
|
Option
|
|
|
That
|
|
|
That
|
|
|
Have Not
|
|
|
Have Not
|
|
|
|
Options
|
|
|
(Unexercisable)
|
|
|
Unearned
|
|
|
Price
|
|
|
Expiration
|
|
|
Have Not
|
|
|
Have Not
|
|
|
Vested
|
|
|
Vested
|
|
|
|
(Exercisable)
|
|
|
(#)
|
|
|
Options
|
|
|
($)
|
|
|
Date
|
|
|
Vested
|
|
|
Vested
|
|
|
(#)
|
|
|
($)
|
|
Name
|
|
(#)
|
|
|
(1)
|
|
|
(#)
|
|
|
(2)
|
|
|
(3)
|
|
|
(#)
|
|
|
($)
|
|
|
(4)
|
|
|
(5)
|
|
|
Christopher T. Clark
|
|
|
23,700
|
|
|
|
|
|
|
|
|
|
|
|
7.63
|
|
|
|
Dec 08,2009
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
16,800
|
|
|
|
|
|
|
|
|
|
|
|
12.48
|
|
|
|
Dec 13,2010
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
24,900
|
|
|
|
|
|
|
|
|
|
|
|
15.58
|
|
|
|
Dec 12,2011
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
69,000
|
|
|
|
|
|
|
|
|
|
|
|
18.49
|
|
|
|
Dec 11,2012
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
59,600
|
|
|
|
|
|
|
|
|
|
|
|
22.14
|
|
|
|
Dec 15,2013
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
41,836
|
|
|
|
|
|
|
|
|
|
|
|
27.45
|
|
|
|
Dec 13,2014
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
36,695
|
|
|
|
18,347
|
|
|
|
|
|
|
|
27.74
|
|
|
|
Dec 13,2015
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
23,700
|
|
|
|
47,400
|
|
|
|
|
|
|
|
31.36
|
|
|
|
Dec 12,2016
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
59,300
|
|
|
|
|
|
|
|
45.15
|
|
|
|
Dec 10,2017
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10,450
|
|
|
|
321,442
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
296,231
|
|
|
|
125,047
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10,450
|
|
|
|
321,442
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
James G. Mosch
|
|
|
23,700
|
|
|
|
|
|
|
|
|
|
|
|
7.63
|
|
|
|
Dec 08,2009
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
16,800
|
|
|
|
|
|
|
|
|
|
|
|
12.48
|
|
|
|
Dec 13,2010
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
24,900
|
|
|
|
|
|
|
|
|
|
|
|
15.58
|
|
|
|
Dec 12,2011
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
69,000
|
|
|
|
|
|
|
|
|
|
|
|
18.49
|
|
|
|
Dec 11,2012
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
59,600
|
|
|
|
|
|
|
|
|
|
|
|
22.14
|
|
|
|
Dec 15,2013
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
41,836
|
|
|
|
|
|
|
|
|
|
|
|
27.45
|
|
|
|
Dec 13,2014
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
36,695
|
|
|
|
18,347
|
|
|
|
|
|
|
|
27.74
|
|
|
|
Dec 13,2015
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10,967
|
|
|
|
21,933
|
|
|
|
|
|
|
|
31.36
|
|
|
|
Dec 12,2016
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
30,500
|
|
|
|
|
|
|
|
45.15
|
|
|
|
Dec 10,2017
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4,850
|
|
|
|
149,186
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
283,498
|
|
|
|
70,780
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4,850
|
|
|
|
149,186
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Brian M. Addison
|
|
|
44,400
|
|
|
|
|
|
|
|
|
|
|
|
7.63
|
|
|
|
Dec 08,2009
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
34,500
|
|
|
|
|
|
|
|
|
|
|
|
12.48
|
|
|
|
Dec 13,2010
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
43,200
|
|
|
|
|
|
|
|
|
|
|
|
15.58
|
|
|
|
Dec 12,2011
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
35,600
|
|
|
|
|
|
|
|
|
|
|
|
18.49
|
|
|
|
Dec 11,2012
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
43,600
|
|
|
|
|
|
|
|
|
|
|
|
22.14
|
|
|
|
Dec 15,2013
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
32,708
|
|
|
|
|
|
|
|
|
|
|
|
27.45
|
|
|
|
Dec 13,2014
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
31,375
|
|
|
|
15,687
|
|
|
|
|
|
|
|
27.74
|
|
|
|
Dec 13,2015
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
9,267
|
|
|
|
18,533
|
|
|
|
|
|
|
|
31.36
|
|
|
|
Dec 12,2016
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
22,000
|
|
|
|
|
|
|
|
45.15
|
|
|
|
Dec 10,2017
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4,100
|
|
|
|
126,116
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
274,650
|
|
|
|
56,220
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4,100
|
|
|
|
126,116
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
25
|
|
|
(1) |
|
Options granted become exercisable over a period of three years
after the date of grant at the rate of one-third per year,
except that they become immediately exercisable upon death,
disability or qualified retirement. Options generally expire ten
years after the date of grant under these plans. The
non-exercisable stock options with the following expiration
dates will vest as indicated below: |
|
|
|
Expiration Date
|
|
Vesting Schedules
|
|
3/22/2015
|
|
The remaining one third will vest March 22, 2008
|
12/13/2015
|
|
The remaining one third will vest December 13, 2008
|
12/12/2016
|
|
One third will vest December 12, 2008, the remaining one third
will vest December 12, 2009
|
12/10/2017
|
|
One third will vest December 10, 2008, one third will vest
December 10, 2009, the remaining one third will vest December
10, 2010
|
|
|
|
(2) |
|
The Companys stock options are granted at the Board
meeting in December of each year to employees already in the
equity incentive program, and to newly hired executives at the
Committee meeting following the executives employment
date. All grants are made at the closing price on the day of the
grant. |
|
(3) |
|
Stock options expire ten years after the grant date. |
|
(4) |
|
Restricted stock unit grants are cliff vested. Restrictions
lapse and the units convert to shares of stock three years after
the date of grant, except that they become immediately vested
upon death, disability or qualified retirement. Restricted stock
units have no expiration date. The restricted stock units were
granted February 5, 2007 and will be fully vested
February 5, 2010. With respect to Bret W. Wise, William R.
Jellison and Christopher T. Clark, vesting of restricted stock
units is contingent upon the continued profitability of the
Company. |
|
(5) |
|
The market value represents the number of restricted stock units
granted multiplied by stock closing price on the day the board
of directors approved the grant. |
All
Other Compensation
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ESOP Stock
|
|
|
401(k)
|
|
|
SERP
|
|
|
Perquisites >
|
|
|
Total Other
|
|
|
|
Contribution
|
|
|
Contribution
|
|
|
Contribution
|
|
|
$10,000
|
|
|
Compensation
|
|
Name of Executive Officer
|
|
($)(1)
|
|
|
($)(2)
|
|
|
($)(3)
|
|
|
($)
|
|
|
($)
|
|
|
Bret W. Wise
|
|
|
803
|
|
|
|
6,750
|
|
|
|
107,583
|
|
|
|
|
|
|
|
115,136
|
|
William R. Jellison
|
|
|
803
|
|
|
|
6,750
|
|
|
|
53,471
|
|
|
|
|
|
|
|
61,024
|
|
Christopher T. Clark
|
|
|
803
|
|
|
|
6,750
|
|
|
|
63,041
|
|
|
|
|
|
|
|
70,594
|
|
James G. Mosch
|
|
|
803
|
|
|
|
6,750
|
|
|
|
41,935
|
|
|
|
|
|
|
|
49,488
|
|
Brian M. Addison
|
|
|
803
|
|
|
|
6,750
|
|
|
|
42,637
|
|
|
|
|
|
|
|
50,190
|
|
|
|
|
(1) |
|
Represents the cost basis of allocations to each of the Named
Executive Officers DENTSPLY Employee Stock Ownership Plan
(ESOP) balances for the year ended 12/31/2007.
Pursuant to the terms of the ESOP Plan, non-vested ESOP shares
forfeited by terminated employees, and dividends earned on the
forfeited shares, are redistributed to the current ESOP
participants, thus reducing the companys contribution
requirement. The ESOP is a non-contributory defined contribution
plan. |
|
(2) |
|
Represents the non-elective cash contributions by the Company
into a 401(k) savings plan for each of the Named Executive
Officers. |
|
(3) |
|
Represents Company credits for the 2007 Plan year to the
DENTSPLY International Supplemental Executive Retirement Plan, a
non-contributory retirement plan for a select group of
management and/or highly compensated employees. Additional
information is provided in the Non-Qualified Deferred
Compensation section. |
26
Option
Exercises and Stock Vested
The following table sets forth certain information with respect
to the exercise of options and stock vested during the year
ended December 31, 2007 and the value of options held at
that date.
Option
Exercises and Stock Vested
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Option Awards
|
|
|
Stock Awards
|
|
|
|
Number of
|
|
|
Value
|
|
|
Number of
|
|
|
Value
|
|
|
|
Shares Acquired
|
|
|
Realized on
|
|
|
Shares Acquired
|
|
|
Realized on
|
|
|
|
on Exercise
|
|
|
Exercise
|
|
|
on Vesting
|
|
|
Vesting
|
|
Name
|
|
(#)
|
|
|
($)
|
|
|
(#)
|
|
|
($)
|
|
|
Bret W. Wise
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
William R. Jellison
|
|
|
157,800
|
|
|
|
4,757,544
|
|
|
|
|
|
|
|
|
|
Christopher T. Clark
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
James G. Mosch
|
|
|
16,200
|
|
|
|
498,434
|
|
|
|
|
|
|
|
|
|
Brian M. Addison
|
|
|
35,400
|
|
|
|
1,089,173
|
|
|
|
|
|
|
|
|
|
Non-Qualified
Deferred Compensation
Effective January 1, 1999 and amended December 10,
2002, the Board of Directors of the Company adopted a
Supplemental Executive Retirement Plan (the Plan).
The purpose of the Plan is to provide additional retirement
benefits for a limited group of management employees, including
the named executive officers, whom the Board concluded were not
receiving competitive retirement benefits. Contributions equal
to 11.7% of compensation reduced by ESOP contributions are
allocated to the participants accounts. No actual benefits are
put aside for participants and the participants are general
creditors of the Company for payment of the benefits upon
retirement or termination from the Company. Participants can
elect to have these benefits administered as savings with
interest or stock unit accounts, with stock units being
distributed in the form of Common stock at the time of
distribution.
Upon retirement or termination for any reason, participants in
the Supplemental Executive Retirement Plan are paid the benefits
in their account based on an earlier election to have their
accounts distributed immediately or in annual installments for
up to five (5) years.
In the event of a participants death before his or her
account has been distributed, distribution shall be made to the
beneficiary selected by the participant within thirty
(30) days after the date of death (or, if later, after the
proper beneficiary has been identified.)
In the event of a Change in Control as defined in this Plan,
participants will be given the option to receive the value of
their accounts in lump sums no later than sixty (60) days
after the Change in Control. Optional distributions received
subject to a change in control must represent the entire
Supplemental Executive Retirement Accounts and will be subject
to five percent (5%) penalty reductions.
All distributions under this Plan shall be based upon the amount
credited to a participants account as of the last business
day of the month immediately preceding the date of the
distribution. The amount of installments payable to a
participant electing distribution through installments shall be
determined by dividing the amount credited to the
participants vested account by the remaining number of
installments, including the current installment to be paid. It
is understood that administrative or legal requirements may lead
to a delay between such valuation date and the date of
distribution.
27
The following table sets forth contributions, earnings and
year-end balances for 2007, with respect to non-qualified
deferred compensation plans for the Named Executive Officers.
Non-Qualified
Deferred Compensation
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Executive
|
|
|
Registrant
|
|
|
Aggregate
|
|
|
|
|
|
Aggregate
|
|
|
|
|
|
Contributions
|
|
|
Contributions
|
|
|
Earnings in
|
|
|
Aggregate
|
|
|
Balance at
|
|
|
|
|
|
in Last
|
|
|
in Last
|
|
|
Last
|
|
|
Withdrawals/
|
|
|
Last Fiscal
|
|
|
|
|
|
Fiscal Year
|
|
|
Fiscal Year
|
|
|
Fiscal Year
|
|
|
Distributions
|
|
|
Year-End
|
|
Name
|
|
Plan Name
|
|
($)(1)
|
|
|
($)(2)
|
|
|
($)(3)
|
|
|
($)(4)
|
|
|
($)
|
|
|
Bret W. Wise
|
|
Supplemental Executive Retirement Plan
|
|
|
|
|
|
|
107,583
|
|
|
|
204,841
|
|
|
|
|
|
|
|
603,700
|
|
William R. Jellison
|
|
Supplemental Executive Retirement Plan
|
|
|
|
|
|
|
53,471
|
|
|
|
283,259
|
|
|
|
|
|
|
|
834,809
|
|
Christopher T. Clark
|
|
Supplemental Executive Retirement Plan
|
|
|
|
|
|
|
63,041
|
|
|
|
176,362
|
|
|
|
|
|
|
|
519,768
|
|
James G. Mosch
|
|
Supplemental Executive Retirement Plan
|
|
|
|
|
|
|
41,935
|
|
|
|
144,228
|
|
|
|
|
|
|
|
425,063
|
|
Brian M. Addison
|
|
Supplemental Executive Retirement Plan
|
|
|
|
|
|
|
42,637
|
|
|
|
180,680
|
|
|
|
|
|
|
|
532,494
|
|
|
|
|
(1) |
|
Participants in the Supplemental Executive Retirement Plan
cannot contribute to the plan. |
|
(2) |
|
Amounts represent unfunded credits allocated to
participants accounts in 2007. They are reported on the
participants plan summary statements for the period ending
December 31, 2007 and included in the All Other
Compensation column in the Summary Compensation Table. |
|
(3) |
|
Participants can elect to have these benefits administered as
savings with interest or stock unit accounts, with stock units
being distributed in the form of Common Stock at the time of
distribution. The amounts represent unfunded interest,
appreciation, and/or dividend credits allocated to
participants accounts in 2007. Earnings are calculated
using market rates. For this reason these amounts are not
reported in the All Other Compensation column in the
Summary Compensation Table. Earnings are not reported to the
Internal Revenue Service until withdrawn. |
|
(4) |
|
There were no distributions to any of the Named Executive
Officers in 2007. |
The table below discloses potential distributions of the
Supplemental Executive Retirement Plan for the Named Executive
Officers if they terminated as of December 31, 2007.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Termination by
|
|
|
|
Termination
|
|
|
|
|
|
|
Employee
|
|
Employee with
|
|
Termination by
|
|
After Change in
|
|
|
|
|
Retirement
|
|
Resignation
|
|
Cause
|
|
Company
|
|
Control
|
|
Death
|
Name of Officer
|
|
($)
|
|
($)
|
|
($)
|
|
($)
|
|
($)
|
|
($)
|
|
Bret W. Wise(1)
|
|
603,700
|
|
603,700
|
|
818,867
|
|
818,867
|
|
926,450
|
|
603,700
|
Frequency and
Duration of Payment
|
|
Lump Sum
|
|
Lump Sum
|
|
Lump Sum
|
|
Lump Sum
|
|
Lump Sum
|
|
Lump Sum
|
|
|
|
|
|
|
|
|
|
|
|
|
|
William R. Jellison (2)
|
|
834,809
|
|
834,809
|
|
941,751
|
|
941,751
|
|
995,221
|
|
834,809
|
Frequency and
Duration of Payment
|
|
Annual Installment
for 5 Years
|
|
Annual Installment
for 5 Years
|
|
Annual Installment
for 5 Years
|
|
Annual Installment
for 5 Years
|
|
Lump Sum
|
|
Lump Sum After
5 Years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Christopher T. Clark (3)
|
|
519,768
|
|
519,768
|
|
645,851
|
|
645,851
|
|
708,892
|
|
519,768
|
Frequency and
Duration of Payment
|
|
Lump Sum
|
|
Lump Sum
|
|
Lump Sum
|
|
Lump Sum
|
|
Lump Sum
|
|
Lump Sum
|
|
|
|
|
|
|
|
|
|
|
|
|
|
James G. Mosch (4)
|
|
425,063
|
|
425,063
|
|
508,932
|
|
508,932
|
|
508,932
|
|
425,063
|
Frequency and
Duration of Payment
|
|
Lump Sum
|
|
Lump Sum
|
|
Lump Sum
|
|
Lump Sum
|
|
Lump Sum
|
|
Lump Sum
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Brian M. Addison (5)
|
|
532,494
|
|
532,494
|
|
617,767
|
|
617,767
|
|
660,404
|
|
532,494
|
Frequency and
Duration of Payment
|
|
Annual Installment
for 3 Years
|
|
Annual Installment
for 3 Years
|
|
Annual Installment
for 3 Years
|
|
Annual Installment
for 3 Years
|
|
Lump Sum
|
|
Lump Sum
|
|
|
|
(1) |
|
Mr. Wises Supplemental Executive Retirement Plan
(SERP) account balance was $603,700 as of
December 31, 2007. Mr. Wise would be entitled to
additional contributions to the plan for the years 2008 and
2009, if he terminated his employment with the Company for
cause, was terminated by the Company or there was a change in
control in the Company. Estimated contributions for 2008 and
2009 are based on Mr. Wises salary and bonus
compensation received in 2007 multiplied by 11.7% (combined
award for ESOP and SERP) less the |
28
|
|
|
|
|
ESOP portion ($225,000 maximum salary multiplied by 6%).
Mr. Wise has elected to receive his SERP account
distribution as a lump sum payment. |
|
(2) |
|
Mr. Jellisons SERP account balance was $834,809 as of
December 31, 2007. Mr. Jellison would be entitled to
additional contributions to the plan for the years 2008 and
2009, if he terminated his employment with the Company for
cause, was terminated by the Company or there was a change in
control in the Company. Estimated contributions for 2008 and
2009 are based on Mr. Jellisons salary and bonus
compensation received in 2007 multiplied by 11.7% (combined
award for ESOP and SERP) less the ESOP portion ($225,000 maximum
salary multiplied by 6%). Mr. Jellison has elected to
receive his SERP account distribution in annual installments
over five years. |
|
(3) |
|
Mr. Clarks SERP account balance was $519,768 as of
December 31, 2007. Mr. Clark would be entitled to
additional contributions to the plan for the years 2008 and
2009, if he terminated his employment with the Company for
cause, was terminated by the Company or there was a change in
control in the Company. Estimated contributions for 2008 and
2009 are based on Mr. Clarks salary and bonus
compensation received in 2007 multiplied by 11.7% (combined
award for ESOP and SERP) less the ESOP portion ($225,000 maximum
salary multiplied by 6%). Mr. Clark has elected to receive
his SERP account distribution as a lump sum payment. |
|
(4) |
|
Mr. Moschs SERP account balance was $425,063 as of
December 31, 2007. Mr. Mosch would be entitled to
additional contributions to the plan for the years 2008 and
2009, if he terminated his employment with the Company for
cause, was terminated by the Company or there was a change in
control in the Company. Estimated contributions for 2008 and
2009 are based on Mr. Moschs salary and bonus
compensation received in 2007 multiplied by 11.7% (combined
award for ESOP and SERP) less the ESOP portion ($225,000 maximum
salary multiplied by 6%). Mr. Mosch has elected to receive
his SERP account distribution in a lump sum payment. |
|
(5) |
|
Mr. Addisons SERP account balance was $532,494 as of
December 31, 2007. Mr. Addison would be entitled to
additional contributions to the plan for the years 2008 and
2009, if he terminated his employment with the Company for
cause, was terminated by the Company or there was a change in
control in the Company. Estimated contributions for 2008 and
2009 are based on Mr. Addisons salary and bonus
compensation received in 2007 multiplied by 11.7% (combined
award for ESOP and SERP) less the ESOP portion ($225,000 maximum
salary multiplied by 6%). Mr. Addison has elected to
receive his SERP account distribution in annual installments
over three years. |
Employment
Agreements
The Company is party to employment agreements with all of the
Named Executive Officers. Each of these employment agreements
provides that, upon termination of such individuals
employment with the Company as a result of the employees
death, the Company is obligated to pay the employees
estate the then current base compensation of the employee for a
period of one year following the date of the employees
death, together with the employees pro rata share of any
incentive or bonus payments for the period prior to the
employees death in the year of such death. Each of the
employment agreements also provides that, in the event that the
employees employment is terminated by the Company without
cause (as defined in the employment agreements), or
by the employee with good reason (as described in
the employment agreements), the Company shall pay compensation
and provide benefits for a period (the Termination
Period) beginning on the date of the termination notice
and ending on the earlier of (i) the second annual
anniversary of the date of such termination notice; or
(ii) the date on which the Employee would attain
age 65. During this period, (i) the Company will be
obligated to pay the employee at the rate of salary being paid
immediately before the termination, (ii) the employee will
be entitled to receive bonus and incentive compensation in
accordance with plans approved by the Board of Directors,
(iii) the employee shall not be entitled to receive any
further grants of stock options or equity incentives under any
stock option or similar such plan subsequent to the date of
termination notice, but equity grants shall continue to be
exercisable, (iv) the employee will be entitled to receive
the benefits that would have been accrued by him from
participation under any pension, profit sharing, ESOP or similar
retirement plan or plans of the Company or any Affiliate, and
(v) the employee shall receive continued coverage during
the Termination Period under all employee disability, annuity,
insurance, or other employee welfare benefit plans, programs or
arrangements of the Company or any Affiliate, provided that
29
such coverage shall terminate for any such benefit on the
earlier of the following events: (i) the covered person
becomes eligible for similar type coverage under another
employers group plans; (ii) the covered person
becomes eligible for Medicare health benefits; or (iii) the
covered person fails to pay the premium for such coverage by the
due date thereof. In the event of death of employee during the
Termination Period, the Company shall continue to make payments
for a period that is the lesser of the remainder of the
Termination Period or twelve (12) months, and shall pay any
bonuses due on a pro-rata basis until the date of the
employees death, to the employees designated
beneficiary or, if no beneficiary has been effectively
designated, then to the employees estate.
Each of the employment agreements includes a three (3) year
non-competition commitment and a commitment against disclosure
of the Company confidential information and non-solicitation of
Company employees.
The Company has also entered into employment agreements with
certain other members of senior management having terms similar
to those described above.
Potential
Payments Upon Termination or Change in Control
The tables below represent the amount of compensation to each of
the Named Executive Officers of the Company in the event of
termination from the Company under different circumstances. The
amount due to each officer upon retirement, resignation,
termination by the employee with cause, termination by the
company without cause, termination following a change in control
and in the event of the death of the named executive is
provided. The amounts assume that the date of termination was
December 31, 2007 and include actual amounts earned through
that time and estimates of amounts which would have been paid as
of such date. The stock price of DENTSPLY International was
assumed to remain at $45.02 per share, the closing price on
December 31, 2007. Actual amounts to be paid may differ and
can only be determined in the event of and at the time of the
executives terminations from the Company.
Payments
Made Upon Termination
The named executive officer would be entitled to receive amounts
earned during his employment, regardless of the reason for his
separation from the Company. Those amounts include:
(1) pro rata share of non-equity incentive compensation,
would be paid in February of the year following the year in
which earned;
(2) vested stock options could be exercised within
90 days of termination:
(3) lump sum distributions would be made for amounts
accrued and vested through the Companys Employee Stock
Ownership and 401(k) Plans
(4) distributions would be made based upon prior election
for amounts accrued and vested through the Companys
Supplemental Executive Retirement Plan; and
(5) lump sum distributions would be made for unused
vacation pay.
Payments
Made Upon Retirement
In addition to the items listed above, the named executive
officer would be entitled to the following:
(1) all outstanding stock options and RSUs would vest as of
the date of a qualified retirement (age 65, or age 60
with fifteen years of service), and the options expire the
earlier of 5 years from that date or the original
expiration date;
30
Payments
Made Upon Termination For Cause by the Executive, or Termination
by the Company Without Cause
If a Named Executive Officer separates from the Company with
cause, or if the Company terminates the executive without cause,
the Named Executive Officer would be entitled, for a period (the
Termination Period) beginning on the date of the
termination notice and ending on the earlier of: (i) the
second annual anniversary of the date of such termination
notice; or (ii) the date on which the Employee would attain
age 65, to the following:
(1) full rate of salary immediately preceding the date of
notice of termination, the first six months to be paid in a lump
sum at the end of such six month period, and thereafter to be
paid bi-weekly;
(2) non-equity incentive compensation in accordance with
the Annual Incentive Plan and based on the rate of salary
immediately preceding the date of notice of termination, paid in
February in the year following the year in which earned;
(3) the employee shall not be entitled to receive any
further grants of stock options or equity incentives under any
stock option or similar such plan subsequent to the date of
termination notice, but equity grants shall continue to be
exercisable;
(4) benefits that would have been accrued by him from
participation under any pension, profit sharing, Employee Stock
Ownership (ESOP) or similar retirement plan or plans of the
Company or any Affiliate;
(5) the employee shall receive continued coverage during
the Termination Period under all employee disability, annuity,
insurance, or other employee welfare benefit plans, programs or
arrangements of the Company or any Affiliate, provided that such
coverage shall terminate for any such benefit on the earlier of
the following events:
a. the employee becomes eligible for similar type coverage
under another employers group plans;
b. the employee becomes eligible for Medicare health
benefits; or
c. the employee fails to pay the premium for such coverage
by the due date thereof.
Payments
Made Upon Termination of Employment by the Executive For Cause
or the Company Terminates or Gives Written Notice of Termination
to the Employee within Two (2) Years after a Change of
Control
If, within two (2) years after a Change of Control the
Named Executive terminates employment for cause, or the Company
terminates or gives written notice of termination of employment
to the Named Executive (regardless of whether with or without
cause), the Company shall pay the following amounts to the Named
Executive in a single lump sum cash payment within five
(5) business days of such termination (provided, that any
amount that would be payable to the Named Executive during the
six-month period beginning on his date of termination and which
would not otherwise be exempt from the application of
Section 409A(a)(2)(B) of the Code shall be withheld and
paid instead on the six (6) month anniversary of the date
of termination.
(1) An amount equal to three (3) times the
Executives current annual salary for Messrs. Wise,
Jellison, Clark, and Addison, and an amount equal to two
(2) times the Executives current annual salary for
Mr. Mosch;
(2) An amount equal to three (3) times the
Executives Annual Incentive bonus for Messrs. Wise,
Jellison, Clark, and Addison, and an amount equal to two
(2) times the Executives Annual Incentive bonus for
Mr. Mosch, for the year in which the termination occurs
based on the target of 100% achievement; and
(3) An amount equal to the benefits that would have been
accrued by the Named Executive for the three (3) year
period from the date of termination for Messrs. Wise,
Jellison, Clark, and Addison, and for the two (2) year
period from the date of termination for Mr. Mosch, from
participation by the Employee under any pension, profit sharing,
employee stock ownership plan (ESOP) Supplemental
Executive Retirement Plan (SERP) or similar
retirement plan or plans of the Company or any Affiliate in
which the Employee participated immediately before the
termination, in accordance with the terms of any such plan (or,
if not available, in lieu thereof be compensated for such
benefits), based on service and compensation the Employee would
have had during such period.
31
(4) Continued coverage for a two (2) year period from
the date of termination under all employee disability, annuity,
insurance, or other employee welfare benefit plans, programs or
arrangements of the Company or any Affiliate in which the Named
Executive participated immediately before the notice of
termination, plus all improvements subsequent thereto (or, if
not available or if required in order to comply with Code
Section 409A, in lieu thereof be compensated in monthly
cash payments for the premium-equivalent amount of such coverage
and then be permitted to purchase such coverage, if available,
by paying 100% of the premium cost for such coverage on an
after-tax basis).
Certain
Adjustments in Payments to Executive
(1) In the event that it shall be determined that any
payment or distribution by the Company to or for the benefit of
the Executive as described above, whether paid or payable or
distributed or distributable pursuant to the terms of this
Agreement or otherwise (a Payment), would constitute
an excess parachute payment within the meaning of
Section 280G of the Code, the Company shall pay the
Executive an additional amount (the
Gross-Up
Payment) such that the net amount retained by the
Executive after deduction of any excise tax imposed under
section 4999 of the Code, and any federal, state and local
income tax, employment tax, excise tax and other tax imposed
upon the
Gross-Up
Payment, shall be equal to the Payment.
(2) If the net after-tax benefit to the Executive of
receiving the
Gross-Up
Payment does not exceed the Safe Harbor Amount (as defined
below) by more than 10% (as compared to the net after-tax
benefit to the Executive resulting from elimination of the
Gross-Up
Payment and reduction of the Payments to the Safe Harbor
Amount), then (i) the Company shall not pay the Executive
the Gross-Up
Payment, and (ii) the provisions of paragraph
(3) below shall apply. The term Safe Harbor
Amount means the maximum dollar amount of parachute
payments that may be paid to the Participate under
section 280G of the Code without imposition of an excise
tax under section 4999 of the Code.
(3) If the Company is not required to pay the Employee a
Gross-Up
Payment as a result of the provisions of Paragraph
(2) above, the Company will apply a limitation on the
Payment amount as follows: The aggregate present value of the
benefits paid to the Executive (the Separation
Benefits) shall be reduced (but not below zero) to the
Reduced Amount. The Reduced Amount shall be an
amount expressed in present value which maximizes the aggregate
present value of such Separation Benefits without causing any
Payment to be subject to the limitation of deduction under
section 280G of the Code.
Payments
Due Upon Death
If a named officer separates from the Company due to death, the
named executive officers beneficiaries would be entitled
to the following:
(1) salary at the rate immediately preceding the date of
death for a period of one year from the date of death;
(2) pro-rata share of non-equity incentive compensation
based on the rate of salary immediately preceding the date of
death, paid in February of the year following the year in which
earned;
(3) all outstanding stock options would vest as of the date
of death and would be exercisable until the earlier of the
stated expiration date of the option, or one (1) year from
the date of death; and
(4) contributions would be made to the Employee Stock
Ownership, 401(k) and Supplemental Executive Retirement Plans
for the year of the death and lump sum distributions would be
made to the beneficiaries; and
32
Bret W.
Wise
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Termination by
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Employee
|
|
|
Employee
|
|
|
Termination
|
|
|
Termination After
|
|
|
|
|
|
|
Retirement
|
|
|
Resignation
|
|
|
with Cause
|
|
|
by Company
|
|
|
Change in Control
|
|
|
Death
|
|
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
Salary
|
|
|
|
|
|
|
|
|
|
|
1,400,000
|
|
|
|
1,400,000
|
|
|
|
2,100,000
|
|
|
|
700,000
|
|
Non Equity Incentive Compensation Plan
|
|
|
700,000
|
|
|
|
700,000
|
|
|
|
1,400,000
|
|
|
|
1,400,000
|
|
|
|
2,100,000
|
|
|
|
700,000
|
|
Stock Options
|
|
|
8,310,089
|
|
|
|
8,310,089
|
|
|
|
11,150,783
|
|
|
|
11,150,783
|
|
|
|
11,150,783
|
|
|
|
11,150,783
|
|
Stock Awards & Dividends
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,315,627
|
|
|
|
1,315,627
|
|
Employee Stock Ownership Plan
|
|
|
100,541
|
|
|
|
100,541
|
|
|
|
121,091
|
|
|
|
121,091
|
|
|
|
127,841
|
|
|
|
100,541
|
|
401(k)
|
|
|
6,750
|
|
|
|
6,750
|
|
|
|
13,500
|
|
|
|
13,500
|
|
|
|
20,250
|
|
|
|
6,750
|
|
Supplemental Executive Retirement Plan
|
|
|
603,700
|
|
|
|
603,700
|
|
|
|
818,867
|
|
|
|
818,867
|
|
|
|
926,450
|
|
|
|
603,700
|
|
Medical, Dental, Vision and Personal Accident Insurances
|
|
|
|
|
|
|
|
|
|
|
22,776
|
|
|
|
22,776
|
|
|
|
22,776
|
|
|
|
|
|
Long Term Disability Insurance
|
|
|
|
|
|
|
|
|
|
|
880
|
|
|
|
880
|
|
|
|
880
|
|
|
|
|
|
Basic Life and Accidental Death and Dismemberment Insurance
|
|
|
|
|
|
|
|
|
|
|
1,380
|
|
|
|
1,380
|
|
|
|
1,380
|
|
|
|
|
|
Gross-Up
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,806,636
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
9,721,081
|
|
|
|
9,721,081
|
|
|
|
14,929,277
|
|
|
|
14,929,277
|
|
|
|
20,572,623
|
|
|
|
14,577,402
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
William
R. Jellison
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Termination by
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Employee
|
|
|
Employee
|
|
|
Termination
|
|
|
Termination After
|
|
|
|
|
|
|
Retirement
|
|
|
Resignation
|
|
|
with Cause
|
|
|
by Company
|
|
|
Change in Control
|
|
|
Death
|
|
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
Salary
|
|
|
|
|
|
|
|
|
|
|
766,000
|
|
|
|
766,000
|
|
|
|
1,149,000
|
|
|
|
383,000
|
|
Non Equity Incentive Compensation Plan
|
|
|
210,650
|
|
|
|
210,650
|
|
|
|
421,300
|
|
|
|
421,300
|
|
|
|
631,950
|
|
|
|
210,650
|
|
Stock Options
|
|
|
7,509,380
|
|
|
|
7,509,380
|
|
|
|
8,437,084
|
|
|
|
8,437,084
|
|
|
|
8,437,084
|
|
|
|
8,437,084
|
|
Stock Awards & Dividends
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
282,566
|
|
|
|
282,566
|
|
Employee Stock Ownership Plan
|
|
|
419,690
|
|
|
|
419,690
|
|
|
|
462,630
|
|
|
|
462,630
|
|
|
|
469,380
|
|
|
|
419,690
|
|
401(k)
|
|
|
6,750
|
|
|
|
6,750
|
|
|
|
13,500
|
|
|
|
13,500
|
|
|
|
20,250
|
|
|
|
6,750
|
|
Supplemental Executive Retirement Plan
|
|
|
834,809
|
|
|
|
834,809
|
|
|
|
941,751
|
|
|
|
941,751
|
|
|
|
995,221
|
|
|
|
834,809
|
|
Medical, Dental, Vision and Personal Accident Insurances
|
|
|
|
|
|
|
|
|
|
|
23,813
|
|
|
|
23,813
|
|
|
|
23,813
|
|
|
|
|
|
Long Term Disability Insurance
|
|
|
|
|
|
|
|
|
|
|
880
|
|
|
|
880
|
|
|
|
880
|
|
|
|
|
|
Basic Life and Accidental Death and Dismemberment Insurance
|
|
|
|
|
|
|
|
|
|
|
1,380
|
|
|
|
1,380
|
|
|
|
1,380
|
|
|
|
|
|
Gross-Up
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
8,981,279
|
|
|
|
8,981,279
|
|
|
|
11,068,337
|
|
|
|
11,068,337
|
|
|
|
12,011,524
|
|
|
|
10,574,549
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
33
Christopher
T. Clark
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Termination by
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Employee
|
|
|
Employee
|
|
|
Termination
|
|
|
Termination After
|
|
|
|
|
|
|
Retirement
|
|
|
Resignation
|
|
|
with Cause
|
|
|
by Company
|
|
|
Change in Control
|
|
|
Death
|
|
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
Salary
|
|
|
|
|
|
|
|
|
|
|
900,000
|
|
|
|
900,000
|
|
|
|
1,350,000
|
|
|
|
450,000
|
|
Non Equity Incentive Compensation Plan
|
|
|
337,500
|
|
|
|
337,500
|
|
|
|
675,000
|
|
|
|
675,000
|
|
|
|
1,012,500
|
|
|
|
337,500
|
|
Stock Options
|
|
|
7,053,368
|
|
|
|
7,053,368
|
|
|
|
8,017,888
|
|
|
|
8,017,888
|
|
|
|
8,017,888
|
|
|
|
8,017,888
|
|
Stock Awards & Dividends
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
472,450
|
|
|
|
472,450
|
|
Employee Stock Ownership Plan
|
|
|
1,166,448
|
|
|
|
1,166,448
|
|
|
|
1,261,776
|
|
|
|
1,261,776
|
|
|
|
1,268,526
|
|
|
|
1,166,448
|
|
401(k)
|
|
|
6,750
|
|
|
|
6,750
|
|
|
|
13,500
|
|
|
|
13,500
|
|
|
|
20,250
|
|
|
|
6,750
|
|
Supplemental Executive Retirement Plan
|
|
|
519,768
|
|
|
|
519,768
|
|
|
|
645,851
|
|
|
|
645,851
|
|
|
|
708,892
|
|
|
|
519,768
|
|
Medical, Dental, Vision and Personal Accident Insurances
|
|
|
|
|
|
|
|
|
|
|
22,776
|
|
|
|
22,776
|
|
|
|
22,776
|
|
|
|
|
|
Long Term Disability Insurance
|
|
|
|
|
|
|
|
|
|
|
880
|
|
|
|
880
|
|
|
|
880
|
|
|
|
|
|
Basic Life and Accidental Death and Dismemberment Insurance
|
|
|
|
|
|
|
|
|
|
|
1,380
|
|
|
|
1,380
|
|
|
|
1,380
|
|
|
|
|
|
Gross-Up
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,284,743
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
9,083,834
|
|
|
|
9,083,834
|
|
|
|
11,539,051
|
|
|
|
11,539,051
|
|
|
|
14,160,285
|
|
|
|
10,970,804
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
James G.
Mosch
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Termination by
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Employee
|
|
|
Employee
|
|
|
Termination
|
|
|
Termination After
|
|
|
|
|
|
|
Retirement
|
|
|
Resignation
|
|
|
with Cause
|
|
|
by Company
|
|
|
Change in Control
|
|
|
Death
|
|
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
Salary
|
|
|
|
|
|
|
|
|
|
|
684,000
|
|
|
|
684,000
|
|
|
|
684,000
|
|
|
|
342,000
|
|
Non Equity Incentive Compensation Plan
|
|
|
188,100
|
|
|
|
188,100
|
|
|
|
376,200
|
|
|
|
376,200
|
|
|
|
376,200
|
|
|
|
188,100
|
|
Stock Options
|
|
|
6,879,435
|
|
|
|
6,879,435
|
|
|
|
7,496,076
|
|
|
|
7,496,076
|
|
|
|
7,496,076
|
|
|
|
7,496,076
|
|
Stock Awards & Dividends
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
219,271
|
|
|
|
219,271
|
|
Employee Stock Ownership Plan
|
|
|
833,418
|
|
|
|
833,418
|
|
|
|
905,383
|
|
|
|
905,383
|
|
|
|
905,383
|
|
|
|
833,418
|
|
401(k)
|
|
|
6,750
|
|
|
|
6,750
|
|
|
|
13,500
|
|
|
|
13,500
|
|
|
|
13,500
|
|
|
|
6,750
|
|
Supplemental Executive Retirement Plan
|
|
|
425,063
|
|
|
|
425,063
|
|
|
|
508,932
|
|
|
|
508,932
|
|
|
|
508,932
|
|
|
|
425,063
|
|
Medical, Dental, Vision and Personal Accident Insurances
|
|
|
|
|
|
|
|
|
|
|
23,499
|
|
|
|
23,499
|
|
|
|
23,499
|
|
|
|
|
|
Long Term Disability Insurance
|
|
|
|
|
|
|
|
|
|
|
880
|
|
|
|
880
|
|
|
|
880
|
|
|
|
|
|
Basic Life and Accidental Death and Dismemberment Insurance
|
|
|
|
|
|
|
|
|
|
|
1,380
|
|
|
|
1,380
|
|
|
|
1,380
|
|
|
|
|
|
Gross-Up
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
8,332,766
|
|
|
|
8,332,766
|
|
|
|
10,009,850
|
|
|
|
10,009,850
|
|
|
|
10,229,121
|
|
|
|
9,510,678
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
34
Brian M.
Addison
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Termination by
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Employee
|
|
|
Employee
|
|
|
Termination
|
|
|
Termination After
|
|
|
|
|
|
|
Retirement
|
|
|
Resignation
|
|
|
with Cause
|
|
|
by Company
|
|
|
Change in Control
|
|
|
Death
|
|
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
Salary
|
|
|
|
|
|
|
|
|
|
|
662,000
|
|
|
|
662,000
|
|
|
|
993,000
|
|
|
|
331,000
|
|
Non Equity Incentive Compensation Plan
|
|
|
165,500
|
|
|
|
165,500
|
|
|
|
331,000
|
|
|
|
331,000
|
|
|
|
496,500
|
|
|
|
165,500
|
|
Stock Options
|
|
|
7,240,291
|
|
|
|
7,240,291
|
|
|
|
7,764,523
|
|
|
|
7,764,523
|
|
|
|
7,764,523
|
|
|
|
7,764,523
|
|
Stock Awards & Dividends
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
185,363
|
|
|
|
185,363
|
|
Employee Stock Ownership Plan
|
|
|
700,060
|
|
|
|
700,060
|
|
|
|
762,669
|
|
|
|
762,669
|
|
|
|
769,419
|
|
|
|
700,060
|
|
401(k)
|
|
|
6,750
|
|
|
|
6,750
|
|
|
|
13,500
|
|
|
|
13,500
|
|
|
|
20,250
|
|
|
|
6,750
|
|
Supplemental Executive Retirement Plan
|
|
|
532,494
|
|
|
|
532,494
|
|
|
|
617,767
|
|
|
|
617,767
|
|
|
|
660,404
|
|
|
|
532,494
|
|
Medical, Dental, Vision and Personal Accident Insurances
|
|
|
|
|
|
|
|
|
|
|
23,499
|
|
|
|
23,499
|
|
|
|
23,499
|
|
|
|
|
|
Long Term Disability Insurance
|
|
|
|
|
|
|
|
|
|
|
880
|
|
|
|
880
|
|
|
|
880
|
|
|
|
|
|
Basic Life and Accidental Death and Dismemberment Insurance
|
|
|
|
|
|
|
|
|
|
|
1,372
|
|
|
|
1,372
|
|
|
|
1,372
|
|
|
|
|
|
Gross-Up
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
681,090
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
8,645,094
|
|
|
|
8,645,094
|
|
|
|
10,177,209
|
|
|
|
10,177,209
|
|
|
|
11,596,299
|
|
|
|
9,685,689
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
COMPENSATION
OF DIRECTORS
Members of the Board of Directors who are not employees of the
Company (Outside Directors) received an annual fee
in 2007 of $40,000. Outside Directors who were chairpersons of
the Human Resources and Governance Committees received an
additional annual fee of $7,500, the chairperson of the Audit
and Finance Committee received an additional annual fee of
$10,000 and the Lead Director received an additional annual fee
of $10,000. Directors also received a fee of $1,500 for each
Board and committee meeting attended and $1,000 for each Board
and committee meeting attended via teleconferencing in 2007. As
of March 17, 2008, these fees remain the same. Annual fees
are paid quarterly. Each Outside Director receives equity
incentive grants, currently stock options and restricted stock
units, as fixed from time to time by the Board. In 2007, the
equity incentive compensation for directors was set at an
expected annual value of $90,000, using the binomial method of
calculation, however, because of the change in timing of equity
grants, as described in footnote 3 below, the actual grant
values varied for the directors. There were 50,924 nonqualified
stock options and 8,630 restricted stock units granted to
directors collectively in 2007. Directors are reimbursed for
travel and other expenses relating to attendance at Board and
Committee meetings.
Effective January 1, 1997, the Company established a
Directors Deferred Compensation Plan (the Deferred
Plan). The Deferred Plan permits Outside Directors to
elect to defer receipt of directors fees or other
compensation for their services as directors. Outside Directors
can elect to have their deferred payments administered as a cash
with interest account or a stock unit account. Distributions to
a director under the Deferred Plan will not be made to any
Outside Director until the Outside Director ceases to be a Board
member.
35
The following table shows the compensation paid to the
Companys Outside Directors for the year ended
December 31, 2007.
2007 Directors
Compensation
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pension Value and
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nonqualified
|
|
|
|
|
|
|
|
|
|
Fees Earned
|
|
|
|
|
|
|
|
|
Non-Equity
|
|
|
Deferred
|
|
|
|
|
|
|
|
|
|
or Paid
|
|
|
|
|
|
|
|
|
Incentive Plan
|
|
|
Compensation
|
|
|
All Other
|
|
|
|
|
|
|
in Cash
|
|
|
Stock Awards
|
|
|
Option Awards
|
|
|
Compensation
|
|
|
Earnings
|
|
|
Compensation
|
|
|
Total
|
|
Name(1)
|
|
($)
|
|
|
($)(2)
|
|
|
($)(3)
|
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
Michael C. Alfano (4)
|
|
|
56,000
|
|
|
|
31,491
|
|
|
|
234,771
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
322,262
|
|
Eric K. Brandt (5)
|
|
|
59,500
|
|
|
|
31,491
|
|
|
|
43,260
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
134,251
|
|
Paula H. Cholmondeley (6)
|
|
|
57,500
|
|
|
|
31,491
|
|
|
|
56,127
|
|
|
|
|
|
|
|
|
|
|
|
12,000
|
|
|
|
157,118
|
|
Michael J. Coleman (7)
|
|
|
|
|
|
|
31,491
|
|
|
|
6,488
|
|
|
|
|
|
|
|
|
|
|
|
53,500
|
|
|
|
91,479
|
|
Wendy L. Dixon (8)
|
|
|
|
|
|
|
31,491
|
|
|
|
6,488
|
|
|
|
|
|
|
|
|
|
|
|
55,500
|
|
|
|
93,479
|
|
William F. Hecht (9)
|
|
|
|
|
|
|
31,491
|
|
|
|
219,419
|
|
|
|
|
|
|
|
|
|
|
|
69,750
|
|
|
|
320,660
|
|
Leslie A. Jones (10)
|
|
|
|
|
|
|
31,491
|
|
|
|
6,488
|
|
|
|
|
|
|
|
|
|
|
|
53,500
|
|
|
|
91,479
|
|
Francis J. Lunger (11)
|
|
|
|
|
|
|
31,491
|
|
|
|
6,488
|
|
|
|
|
|
|
|
|
|
|
|
58,500
|
|
|
|
96,479
|
|
John C. Miles II (12)
|
|
|
|
|
|
|
31,491
|
|
|
|
6,488
|
|
|
|
|
|
|
|
|
|
|
|
56,500
|
|
|
|
94,479
|
|
W. Keith Smith (13)
|
|
|
|
|
|
|
31,491
|
|
|
|
6,488
|
|
|
|
|
|
|
|
|
|
|
|
63,750
|
|
|
|
101,729
|
|
|
|
|
(1) |
|
Mr. Wise is not shown in this table since he was an
employee of the Company as of December 31, 2007. His
compensation is shown in the Summary Compensation Table. |
|
(2) |
|
On July 31, 2007, each member was granted 863 restricted
stock units. The stock price at the close of business on
July 31, 2007 was $36.49. |
|
(3) |
|
In 2007, the Governance Committee of the Board adopted a plan to
move all directors to a May annual grant schedule, rather than
the historic anniversary date grant schedule. Because all
directors were on a grant schedule of every third year, the
Committee implemented a transition plan to effectuate the change
to an annual grant schedule. It will take about three years to
transition all directors to the annual schedule. Under the
transition plan every director will get one grant on the third
anniversary of their last grant, as well as annual grants in
May. The date and amount of the anniversary grant for each
director will vary depending upon when their service began and
when the grant is made. |
|
(4) |
|
Dr. Alfano elected to receive his compensation in the form
of cash. Compensation to Dr. Alfano consisted of fees of
$16,000 for attending Board and committee meetings and the
Annual fee of $40,000. Dr Alfano received grants of 20,000
options on February 14, 2007, his anniversary of service on
the Board, and 481 options on July 31, 2007. |
|
(5) |
|
Mr. Brandt elected to receive his compensation in the form
of cash. Compensation to Mr. Brandt consisted of fees of
$19,500 for attending Board and committee meetings and the
Annual fee of $40,000. Mr. Brandt received grants of 481
options on July 31, 2007 and 2,460 options on
November 1, 2007, his anniversary of service on the Board. |
|
(6) |
|
For 2007, Ms. Cholmondeley elected to receive her
compensation in the form of cash and deferral to stock units
with dividends. Compensation to Ms. Cholmondeley consisted
of fees of $19,500 for attending Board and committee meetings
and the Annual fee of $50,000, which included the fee for
chairing the Audit and Finance Committee. Ms. Cholmondeley
received grants of 481 options on July 31, 2007 and 3,654
options on August 31, 2007 her anniversary of service on
the Board. |
|
(7) |
|
For 2007, Mr. Coleman elected to receive his compensation
in the form of deferral to a savings account with interest. His
compensation consisted of fees of $13,500 for attending Board
and committee meetings and the Annual fee of $40,000.
Mr. Coleman received a grant of 481 options on
July 31, 2007. |
36
|
|
|
(8) |
|
For 2007, Dr. Dixon elected to receive her compensation in
the form of deferral to stock units with dividends. Her
compensation consisted of fees of $15,500 for attending Board
and committee meetings and the Annual fee of $40,000.
Dr. Dixon received a grant of 481 options on July 31,
2007. |
|
(9) |
|
For 2006, Mr. Hecht elected to receive his compensation in
the form of deferral to stock units with dividends. Compensation
to Mr. Hecht consisted of fees of $16,000 for attending
Board and committee meetings and the Annual fee of $53,750,
which included the fee for chairing the Human Resources
Committee for the full year and serving as the Lead Director
role in 2007. Mr. Hecht received grants of 481 options on
July 31, 2007, and 20,000 options on March, 21 2007, his
anniversary of service on the Board. |
|
(10) |
|
For 2007, Mr. Jones elected to receive his compensation in
the form of deferral to stock units with dividends. Compensation
to Mr. Jones consisted of fees of $13,500 for attending
Board and committee meetings and the Annual fee of $40,000.
Mr. Jones received a grant of 481 options on July 31,
2007. |
|
(11) |
|
For 2007, Mr. Lunger elected to receive his compensation in
the form of deferral to stock units with dividends. His
compensation consisted of fees of $18,500 for attending Board
and committee meetings and the Annual fee of $40,000.
Mr. Lunger received a grant of 481 options on July 31,
2007. |
|
(12) |
|
For 2007, Mr. Miles elected to receive his compensation in
the form of deferral to a savings account with interest.
Compensation to Mr. Miles consisted of fees of $16,500 for
attending Board and committee meetings and the Annual fee of
$40,000. Mr. Miles received a grant of 481 options on
July 31, 2007. |
|
(13) |
|
For 2007, Mr. Smith elected to receive his compensation in
the form of deferral to stock units with dividends. His
compensation consisted of fees of $17,500 for attending Board
and committee meetings and the Annual fee of $46,250, which
included the fee for chairing the Governance Committee.
Mr. Smith received a grant of 481 options on July 31,
2007. |
BOARD OF
DIRECTORS AND COMMITTEES
Board
of Directors Meetings
The Companys Board of Directors held six meetings during
2007, one of which was a telephone meeting. The Board of
Directors has determined that the following directors are
independent under the Listing Standards: Michael C.
Alfano, Eric K. Brandt, Paula H. Cholmondeley, Michael J.
Coleman, Wendy L. Dixon, William F. Hecht, Leslie A. Jones,
Francis J. Lunger, John C. Miles, II and W. Keith Smith. In
determining the independence of Dr. Alfano, the Board
considered the fact that Dr. Alfano is the Executive Vice
President of New York University and from time to time the
Company sells products to the New York University College of
Dentistry. The Board determined that Dr. Alfano has no
personal interest or involvement in such transactions and that
such transactions are conducted by the relevant businesspeople
on an arms length basis with the College of Dentistry. The Board
has an Executive Committee, an Audit Committee, a Corporate
Governance and Nominating Committee (Governance
Committee) and a Human Resources Committee. No directors
attended fewer than 75% of the total number of meetings of the
Board and the meetings of any committee of the Board on which a
director served during the year ended December 31, 2007.
The current composition and activities of the Committees are
described below.
Executive
Committee
The Executive Committee acts for the Board and provides guidance
to the executive officers of the Company between meetings of the
Board. The members of the Executive Committee in 2007 were
Messrs. Hecht, Jones, Miles and Wise. The Executive
Committee held two meetings during 2007, both of which were
telephone meetings. The Executive Committee members remain the
same as of March 17, 2008.
Audit
Committee
The Audit Committee is responsible for selecting and retaining
the independent registered public accounting firm, setting the
independent registered public accounting firms
compensation, pre-approving all auditing and permitted non-audit
services by the independent registered public accounting firm,
reviewing with the independent registered public accounting firm
the scope and results of the audit, reviewing the adequacy and
effectiveness of the
37
Companys system of internal control and performing the
other duties set forth in the Audit and Finance Committee
Charter (a copy of the Audit and Finance Committee Charter is
attached to this Proxy Statement as Appendix B).
The members of the Audit Committee in 2007 were
Ms. Cholmondeley (Chairperson), and Messrs. Brandt and
Lunger, all of whom are independent as defined in the Listing
Standards. The Board has determined that Ms. Cholmondeley
and Messrs. Brandt and Lunger are Audit Committee Financial
Experts under the rules and regulations of the Securities and
Exchange Commission. The Audit Committee held nine meetings
during 2007, six of which were telephone meetings. The Audit
Committee members remain the same as of March 17, 2008.
Governance
Committee
The Governance Committee is responsible for identifying and
recommending individuals as nominees to serve on the Board,
reviewing and recommending Board policies and governance
practices and appraising the performance of the Board and
performing the other duties set forth in the Governance
Committee Charter (a copy of the Governance Committee Charter is
attached to this Proxy Statement as Appendix C). The
members of the Committee in 2007 were Messrs. Smith
(Chairman), Jones and Miles and Dr. Dixon, all of whom are
independent as defined in the Listing Standards. The members of
the Governance Committee remain the same as of March 17,
2008.
It is the policy of the Governance Committee to consider any
candidates for nomination to the Board who are recommended and
submitted by security holders in accordance with the
Companys by-laws (see Stockholder Proposals for Proxy
Statement and Nominations in this Proxy Statement). No such
candidates were submitted to the Company for consideration. The
Governance Committees policy is to evaluate any proposed
candidates under the criteria utilized by the Governance
Committee to evaluate all potential nominees, including, at a
minimum, the following attributes:
|
|
|
|
|
the proven ability and experience to bring informed, thoughtful
and well-considered opinions to corporate management and the
Board;
|
|
|
|
the competence, maturity and integrity to monitor and evaluate
the Companys management, performance and policies;
|
|
|
|
the willingness and ability to devote the necessary time and
effort required for service on the Board;
|
|
|
|
the capacity to provide additional strength, diversity of view
and new perceptions to the Board and its activities;
|
|
|
|
the necessary measure of communication skills and
self-confidence to ensure ease of participation in Board
discussion; and
|
|
|
|
who hold or have held a senior position with a significant
business corporation or a position of senior leadership in an
educational, medical, religious, or other non-profit institution
or foundation of significance.
|
When the Governance Committee engages in a process to identify
director candidates, other than directors standing for
re-election, the Governance Committee polls the existing
directors for recommendations and sometimes utilizes the service
of a search firm to identify potential candidates. All potential
candidates are screened relative to their qualifications and go
through an interview process with the Governance Committee and,
if desired, by other members of the Board. When the Governance
Committee uses a search firm, a fee is paid for such services.
The Corporate Governance Committee held five meetings during
2007, one of which was a telephone meeting.
Human
Resources Committee
The Human Resources Committee is responsible for evaluating and
administering compensation levels for all senior officers of the
Company, reviewing and evaluating employee compensation
generally, and employee benefit plans and other activities as
set forth in the Human Resources Committee Charter (a copy of
the Human Resources Committee Charter is attached to this Proxy
Statement as Appendix D). Its members in 2007 were
Messrs. Hecht (Chairman) and Coleman and Dr. Alfano,
all of whom are independent as defined in the Listing Standards.
The
38
Human Resources Committee met five times during 2007, two of
which were telephone meetings. The members of the Human
Resources Committee remain the same as of March 17, 2008.
Human
Resources Committee Interlocks and Insider
Participation
None of the current members of the Human Resources Committee has
ever been an officer or employee of DENTSPLY. None of our
executive officers served as a member of the board of directors
or compensation committee of any entity that has one or more
executive officers serving on our Board of Directors or Human
Resources Committee.
Attendance
at Annual Meetings
The Company has no policy regarding the attendance of Board
members at the Companys Annual Stockholders Meeting. In
2007, all Board members attended the Annual Meeting of
Stockholders.
Related
Person Transactions
No related person transactions were noted for the year ended
December 31, 2007.
The Company has a written policy and procedures with respect to
the review and approval of Related Person Transactions. The
Corporate Governance and Nominating Committee (the
Committee) reviews the material facts of all Related
Person Transactions that require the Committees approval
and either approves or disapproves of the entry into the
Transaction, subject to certain identified exceptions described
below. In determining whether to approve or ratify a Related
Person Transaction, the Committee takes into account, among
other factors it deems appropriate, whether the Transaction is
on terms no less favorable than terms generally available to an
unaffiliated third-party under the same or similar circumstances
and the extent of the Related Persons interest in the
Transaction. The Chair of the Committee is delegated the
authority by the Board to approve Related Party Transactions
that, because of timing or scheduling, are not feasible to be
approved by the full Committee.
The policy applies to any transaction, arrangement or
relationship in which the Company (including any of its
subsidiaries) will be a participant and in which any Related
Person (as defined by SEC Rules) will have a direct or indirect
material interest, and the amount involved exceeds $120,000.
The Committee has pre-approved, under the policy, the following
Related Person Transactions without regard to the amount
involved:
1. any Transaction involving the compensation, employment
and/or
benefits of an executive officer of the Company if the
compensation arising from the Transaction is required to be
reported in the Companys proxy statement;
2. any Transaction involving the compensation, employment
and/or
benefits of an executive officer of the Company that is not a
named executive officer (as that term is defined in
Item 402(a)(3) of
Regulation S-K)
if (a) the executive officer is not an immediate family
member of another executive officer or director of the Company,
(b) the compensation arising from the Transaction would
have been reported under Item 402 as compensation earned
for services to the Company if the executive officer was a
named executive officer, and (c) such
compensation had been approved, or recommended to the Board of
Directors of the Company for approval, by the Human Resources
Committee of the Board of Directors;
3. any Transaction involving the compensation, services
and/or
benefits of a director if the compensation arising from the
Transaction is required to be reported in the Companys
proxy statement;
4. any Transaction where the Related Persons interest
arises solely from the ownership of the Companys common
stock and all holders of the Companys common stock
received the same benefit on a pro rata basis;
5. any Transaction with a Related Party involving the
rendering of services as a common or contract carrier, or public
utility, at rates or charges fixed in conformity with law or
governmental authority;
39
6. any Transaction with a Related Party involving services
as a bank depository of funds, transfer agent, registrar,
trustee under a trust indenture, or similar services; and
7. any Transaction in which the interest of the Related
Person arises solely from such persons position as a
director of another firm, corporation or other entity that is a
party to the Transaction.
Except to the extent pre-approved, as noted above, Related
Person Transactions are subject to the following procedures. The
Related Person notifies the General Counsel of the Company of
any proposed Transaction, including: the Related Persons
relationship to the Company and interest in the proposed
Transaction; the material terms of the proposed Transaction; the
benefits to the Company of the proposed Transaction; and the
availability from alternative sources of the products or
services that are the subject of the proposed Transaction.
The proposed Related Person Transaction is submitted to the
Committee for consideration at the next Committee meeting or, if
the legal department, after consultation with the Chief
Executive Officer or the Chief Financial Officer, determines
that the Company should not wait until the next Committee
meeting, to the Chair of the Committee acting pursuant to
authority delegated by the Board. Any Transactions approved
pursuant to delegated authority by the Chair of the committee,
is reported to the Committee at the next Committee meeting.
To the extent the Company becomes aware of a Related Person
Transaction that was not previously approved under this policy,
it shall be promptly reviewed as described above and be
ratified, amended or terminated, as determined appropriate by
the Committee.
40
AUDIT AND
FINANCE COMMITTEE DISCLOSURE
The Audit and Finance Committee (Audit Committee)
was comprised of three directors in 2007, all of whom are
independent as defined by the Listing Standards. In addition,
Mr. Brandt and Ms. Cholmondeley have been designated
by the Board as Audit Committee Financial Experts
under applicable rules and regulations of the Securities and
Exchange Commission. The Audit Committee operates under a
written charter adopted by the Board of Directors. This charter
is reviewed at least annually by the Committee and the Board and
amended as determined appropriate (a copy of this charter is
attached to this Proxy Statement as Appendix B).
The Audit Committee reviews the Companys financial
reporting process on behalf of the Board. In addition, the
Committee approves and retains the Companys independent
registered public accounting firm.
Management is responsible for the Companys internal
controls, including internal control over financial reporting,
and the financial reporting process. The independent registered
public accounting firm is responsible for performing an audit of
the Companys financial statements in accordance with
generally accepted auditing standards and an audit of the
Companys internal control over financial reporting; and to
issue a report thereon. The Committees responsibility is
to oversee these processes.
In this context, the Committee has met and held discussions with
management and PricewaterhouseCoopers LLP (PwC), the
Companys independent registered public accounting firm.
Management represented to the Committee that the Companys
financial statements were prepared in accordance with generally
accepted accounting principles, and the Committee has reviewed
and discussed the audited financial statements with management
and PwC. The Committee discussed with PwC the matters required
to be discussed by Statement on Auditing Standards No. 61
(Communication with Audit Committees).
In addition, the Committee has discussed with PwC the
firms independence from the Company and its management and
has received the written disclosures and the letter from PwC
required by Independence Standards Board Standard No. 1
(Independence Discussions with Audit Committees), as it has been
modified or supplemented.
The Committee discussed with PwC the overall scope and plans for
their audits. The Committee meets with PwC, with and without
management present, to discuss the results of their
examinations, the evaluations of the Companys internal
controls, and the overall quality of the Companys
financial reporting.
Based upon the Committees discussions with management and
PwC and the Committees review of the representations of
management and the report of PwC to the Committee, the Committee
recommended that the Board include the audited financial
statements in the Companys Annual Report on
Form 10-K
for the year ended December 31, 2007 filed with the
Securities and Exchange Commission.
AUDIT AND
FINANCE COMMITTEE
|
|
|
Paula
H. Cholmondeley
|
Eric K. Brandt
|
Francis J. Lunger
|
PROXY
DELIVERY STATEMENT
As permitted by law, one copy of the Companys Proxy
Statement and Annual Report is delivered to stockholders
residing at the same address, unless such stockholders have
notified the Company of their desire to receive multiple copies
of the Proxy Statement and Annual Report. We believe this
Householding approach provides greater convenience
for our stockholders, as well as cost savings for us by reducing
the number of duplicate documents that are sent to the same
address.
The Company will promptly deliver, upon oral or written request,
a separate copy of the Proxy Statement and Annual Report to any
stockholders residing at an address to which only one copy was
delivered. Requests for additional copies should be directed to
Broadridge, either by calling toll-free
(800) 542-1061,
or by writing to Broadridge, Householding Department, 51
Mercedes Way, Edgewood, New York, 11717.
41
Stockholders residing at the same address and currently
receiving multiple copies of the Proxy Statement may also
contact Broadridge, as noted above, to request that only a
single copy of such document be mailed in the future.
We strongly encourage your participation in the Householding
program, and believe that it will benefit both you and the
Company. Not only will it reduce the volume of duplicate
information that you receive in your household, but it will also
reduce our printing and mailing costs.
STOCKHOLDER
COMMUNICATIONS STATEMENT
The Board of Directors has no specific formal process for
security holders to send communications to the Board. The Board
does not believe a specific process is necessary in the event
security holders wish to direct communications to a Board
member. All Board members, including their Committee
assignments, are identified each year in the Companys
Proxy Statement. Communications which are intended for Board
members can be sent to the Company for delivery to individual
Board members. All mail received will be opened and screened for
security purposes and mail determined to be appropriate and
within the purview of the Board will be delivered to the
respective Board member to which the communication is addressed.
Mail addressed to Outside Directors or
Non-Management Directors will be forwarded or
delivered to the Chairman of the Corporate Governance and
Nominating Committee. Mail addressed to the Board of
Directors will be forwarded or delivered to the Chairman
of the Board.
STOCKHOLDER
PROPOSALS FOR PROXY STATEMENT AND NOMINATIONS
Stockholder proposals that are intended to be presented at the
Companys Annual Meeting of Stockholders to be held in 2009
must be received by the Company no later than December 11,
2008 and must otherwise comply with
Rule 14a-8
under the Securities Exchange Act, as amended, in order to be
included in the proxy statement and proxy relating to that
meeting.
The Companys by-laws provide that advance notice of
stockholder-proposed business to be brought before an Annual
Meeting of Stockholders must be given to the Secretary of the
Company not less than 60 days in advance of the date of the
mailing of materials regarding the prior years Annual
Meeting, which mailing date is identified on the Chairmans
letter at the front of the proxy statement. To propose business
for an Annual Meeting, a stockholder must specify in writing the
business desired to be brought before the Annual Meeting and the
reasons for conducting such business at the Annual Meeting, the
proposing stockholders name and address, the class and
number of shares beneficially owned by the stockholder, and any
material interest of the stockholder in such business. In order
to be brought before the 2009 Annual Meeting, stockholders must
notify the Company in writing, in accordance with the procedures
set forth above, of any stockholder-proposed business no later
than February 9, 2009.
The Companys by-laws also provide that a stockholder may
request that persons be nominated for election as directors by
submitting such request, together with the written consent of
the persons proposed to be nominated, to the Secretary of the
Company not less than 60 days prior to the date of the
Annual Meeting. To be in proper form, the nominating stockholder
must set forth in writing, as to each proposed nominee, the
nominees age, business address, residence address,
principal occupation or employment, number of shares of Common
Stock of the Company beneficially owned by such person and such
other information related to such person as is required to be
disclosed by applicable law, and, as to the stockholder
submitting the request, such stockholders name and address
as they appear on the Companys books and the number of
shares of Common Stock of the Company owned beneficially by such
person.
42
FORM 10-K
STOCKHOLDERS MAY OBTAIN AN ADDITIONAL COPY (WITHOUT EXHIBITS) OF
THE COMPANYS ANNUAL REPORT ON
FORM 10-K
FOR THE YEAR ENDED DECEMBER 31, 2007 AS FILED WITH THE
SECURITIES AND EXCHANGE COMMISSION WITHOUT CHARGE BY WRITING TO:
INVESTOR RELATIONS DEPARTMENT, DENTSPLY INTERNATIONAL INC.,
SUSQUEHANNA COMMERCE CENTER, 221 WEST PHILADELPHIA STREET, YORK,
PENNSYLVANIA
17405-0872.
CORPORATE
GOVERNANCE GUIDELINES
During 2007, the Board of Directors made some revisions to its
Corporate Governance Guidelines and Policies. A copy of such
Guidelines and Policies are available on the Companys
website at www.dentsply.com under the Company tab.
OTHER
MATTERS
The Board of Directors knows of no matters which are to be
brought before the Annual Meeting other than those set forth in
this Proxy Statement. If any other matters properly come before
the Annual Meeting, the person named in the enclosed proxy card,
or his duly appointed substitute acting at the Annual Meeting,
will be authorized to vote or otherwise act thereon in
accordance with his judgment on such matters.
43
APPENDIX A
DENTSPLY
International
Executive Pay Analysis
Comparator Companies in $1 $3 Billion Revenue
Group
|
ADVO
|
A.G. Edwards
|
AGL Resources
|
Allergan
|
Alliance Data Systems
|
Alliant Techsystems
|
American United Life
|
American Water Works
|
Ameriprise Financial
|
Ameritrade
|
AMETEK
|
Ann Taylor Stores
|
Applebees International
|
Aquila
|
Arysta LifeScience North America
|
Associated Banc-Corp
|
Austin Industries
|
Auto Club Group
|
Avista
|
Bank North
|
Barnes Group
|
Barrick
|
Beckman Coulter
|
Belo
|
BIC
|
Bob Evans Farms
|
Bracco Diagnostics
|
Brinks
|
Building Materials Holding
|
BWXT Y-12
|
Cabot
|
California Automobile Association
|
Cameron International
|
Capital Blue Cross
|
Carpenter Technology
|
CB Richard Ellis
|
CDI
|
Cephalon
|
Ceridian
|
Chanel
|
Chemtura
|
Cincinnati Bell
|
COACH
|
Columbia Sportswear
|
Commerce Bancorp
|
Commerce Bancshares
|
Compass Bancshares
|
Connell
|
Convergys
|
Cooper Standard Automotive
|
Cooper Tire & Rubber
|
Corn Products
|
Convance
|
CUNA Mutual
|
Cytec
|
Dade Behring
|
Discovery Communications
|
Donaldson
|
Dresser
|
Dynea
|
Dynegy
|
Emdeon
|
Energen
|
Enron
|
Equifax
|
Equitable Resources
|
Erie Insurance
|
Federal Reserve Bank of Cleveland
|
Federal Reserve Bank of Dallas
|
Ferreligas
|
Fleetwood Enterprises
|
Fremont Investment & Loan
|
GATX
|
Genzyme
|
Georgia Gulf
|
Gilead Sciences
|
Great Plans Energy
|
GROWMARK
|
GTECH
|
Harsco
|
Hawaiian Electric
|
Hayes Lemmerz
|
A-1
|
H.B. Fuller
|
Herbalife International of America
|
Hercules
|
Herman Miller
|
Hexcel
|
HNI
|
Hospira
|
Houghton Mifflin
|
Hunt Consolidated
|
Huntington Bancshares
|
IDEX
|
IMS Health
|
IndyMac
|
InterContinental Hotels
|
International Flavors & Fragrances
|
Irvine Company
|
Irving Oil
|
ISP
|
Jack in the Box
|
JEA
|
J.M. Smucker
|
Jostens
|
Kaman Industrial Technologies
|
Kansas City Southern
|
Kennametal
|
Kinder Morgan
|
King Pharmaceuticals
|
Koppers
|
L.L. Bean
|
Magellan Midstream Partners
|
Martin Marietta Materials
|
Mary Kay
|
MasterCard
|
McDermott
|
MDS Laboratory Service
|
Medimmune
|
Mercury Insurance
|
Meredith
|
Metaldyne
|
Mission Foods
|
Modine Manufacturing
|
Molex
|
Monaco Coach
|
Moodys
|
MSC Industrial Direct
|
NASD
|
National Fuel Gas
|
National Semiconductor
|
Navy Federal Credit Union
|
New York Power Authority
|
NorthWestern Energy
|
NRG Energy
|
Oglethorp Power
|
Ohio Casualty
|
Oshkosh Truck
|
Otter Tail
|
Packaging of America
|
Parsons
|
Peoples Energy
|
PerkinElmer
|
Phillips-Van Heusen
|
Phoenix Companies
|
Pinnacle West Capital
|
Plexus
|
PMI Group
|
PNM Resources
|
Portland General Electric
|
Prisma Energy
|
Puget Energy
|
Ralcorp Holdings
|
Rayonier
|
Regal-Beloit
|
Revlon
|
Rich Products
|
Russell
|
Sabre
|
Salt River Project
|
Scotts Miracle-Gro
|
Securian Financial Group
|
Security Benefit Group of Companies
|
Sensata Technologies
|
Shire Pharmaceuticals
|
Solutia
|
Southern Union Company
|
Spansion
|
Sports Authority
|
Springs Global
|
Steelcase
|
St. Jude Medical
|
Targa Resources
|
A-2
|
Thomas & Betts
|
Tiffany
|
Toro
|
Trans Union
|
Travelport
|
True Value Hardware
|
Tupperware
|
UCB
|
UIL Holdings
|
UniSource Energy
|
United States Cellular
|
United States Enrichment
|
Vectren
|
Visa International
|
Visa USA
|
Vistar
|
Vulcan Materials
|
Wamaco
|
Watson Pharmaceuticals
|
Webster Bank
|
Wellcare Health Plans
|
Westar Energy
|
W.R. Grace
|
TOTAL COMPANIES: 196
|
A-3
APPENDIX B
DENTSPLY
International Inc.
Audit & Finance Committee Charter
The primary function of the Audit & Finance Committee
(Committee) is to assist the Board of Directors
(Board) in fulfilling its oversight responsibilities
related to corporate accounting and financial reporting
disclosures, corporate financing activities, treasury activities
and risk management activities. It shall be the policy of the
Committee to maintain free and open communication between the
Board, the independent accountants, the internal auditors and
the management of the Company.
|
|
1.
|
Members The Committee shall be composed of
directors who are independent, as defined by the Securities and
Exchange Commission and NASDAQ, of the management of the Company
and are free of any relationship that, in the opinion of the
Board, would interfere with their exercise of independent
judgment as a committee member. Committee members shall be
nominated by the Board, and the Committee shall be composed of
not less than three independent Directors who meet the NASDAQ
requirements regarding financial knowledge, experience and
expertise.
|
|
2.
|
Meetings The Committee will meet on a regular
basis and special meetings will be called as circumstances
require. The Committee will meet privately from time to time
with representatives of the Companys independent
accountants, the internal auditor and management. Written
minutes will be kept for all meetings.
|
|
3.
|
Funding The Committee shall receive
sufficient funding to carry out its functions, including the
hiring of outside advisors as deemed appropriate by the
Committee.
|
|
|
1. |
Financial Oversight and Reporting The
Committee shall have the role and responsibility for monitoring
and overseeing the management, gathering and reporting of
financial data and information, which shall include:
|
|
|
|
|
A.
|
The appointment, compensation, retention and oversight of the
independent accountants.
|
|
|
|
|
B.
|
Review and approve the plans, scope and results for the annual
audit with the independent accountants and address any
significant financial reporting issues which arose during the
audit and their resolution.
|
|
|
C.
|
Review and approve the plans, scope, budget and results for the
internal audit function and address any significant issues
raised by the internal audit function.
|
|
|
|
|
D.
|
Review significant developments in accounting rules and
recommended changes in the Companys methods of accounting
or financial statements and application of the rules and the
Companys accounting principles to the Companys
financial reporting.
|
|
|
|
|
E.
|
Review and evaluate the adequacy of internal accounting controls
and internal control systems.
|
|
|
2. |
Finance In carrying out its Finance function,
the Committee may undertake such actions as it deems necessary
or useful and providing updates and recommendations to the Board
of Directors which may include:
|
|
|
|
|
A.
|
Capital Structure. Receiving reports from management about the
current capital structure and proposed changes to the capital
structure.
|
|
|
|
|
B.
|
Dividend Policy. Reviewing analyses from management about the
current dividend policy of the Company and provide
recommendation to the Board of Directors.
|
B-1
|
|
|
|
C.
|
Financing Activities. Reviewing analyses from management
including accounting, tax and financing activities associated
with proposed material financing transactions and provide
recommendation to the Board of Directors.
|
|
|
|
|
D.
|
Capital Expenditures. At the request of the Board, review
specific projects proposed by Management as well as perform a
post implementation review of major projects.
|
|
|
|
|
E.
|
Benefit Plan Funding Matters. Reviewing reports from management
concerning the funding requirements for the Companys
employee benefit plans.
|
|
|
|
|
F.
|
Insurance. Reviewing the Companys insurance coverage and
the related costs.
|
|
|
|
|
G.
|
Review and approve policies and procedures with respect to Debt
Management, Financial Risk Management, Credit Management and
Global Cash Investment Management.
|
|
|
H.
|
Review tax compliance programs and the tax optimization
strategies of the company.
|
|
|
|
|
I.
|
Review the financial and accounting components of any material
transactions significantly impacting the company.
|
|
|
3.
|
Information Technology Review information
technology plans with respect to corporate goals, industry
trends, and competitive advantages. Review and assess the
security of computer systems and applications and contingency
plans for computer system breakdowns, particularly with respect
to the processing of financial information.
|
|
4.
|
Complaint Handling Review and approve the
procedures established for the receipt, retention and treatment
of complaints received by the Company regarding accounting,
internal controls or auditing matters.
|
|
5.
|
Outside Advisors The Committee shall directly
engage independent advisors when deemed appropriate by the
Committee.
|
In carrying out its responsibilities, the Committee shall remain
flexible in its policies and procedures in order that it can
best react to changing conditions and environment and to assure
to the directors and shareholders that the corporate accounting,
reporting and financing practices of the Company are in
accordance with all requirements and are of the highest quality.
B-2
APPENDIX C
DENTSPLY
International Inc.
Corporate Governance And Nominating Committee Charter
I. PURPOSE
The primary function of the Corporate Governance and Nominating
Committee (Committee) is to assist the Board of
Directors of the Company (the Board) in the
establishment of criteria for the selection and nomination of
Board members and to establish policies and procedures for the
governance of the Company and the Board. The Committee shall
report to the Board on matters relating to the activities of the
Committee.
II. ORGANIZATION
|
|
A. |
Members. The Committee shall consist of
directors who are independent, as defined by NASDAQ and SEC
rules, and are free from any relationship with the Company or
management of the Company that, in the opinion of the Board as
evidenced by its election of such Committee members, would
interfere with the exercise of independent judgment as a
Committee member.
|
|
|
B. |
Meetings. The Committee will meet as
often as necessary to carry out its responsibilities. Meetings
may be called by the Chairman of the Committee
and/or
management of the Company. Written minutes of each meeting shall
be duly filed in the Company records. Reports of meetings of the
Committee shall be made to the Board accompanied by any
recommendations to the Board for matters that the Committee
determines requires approval of the Board.
|
III. FUNCTIONS
The Committee shall have the following specific responsibilities:
|
|
|
|
|
Review the qualifications of and recommend to the Board
(i) those persons to be nominated for membership on the
Board who shall be submitted to the shareholders for election at
each Annual Meeting of Shareholders, including consideration of
candidates recommended by shareholders in accordance with the
by-laws and procedures of the Company and (ii) the nominees
for directors to be elected by the Board to fill vacancies and
newly created directorships;
|
|
|
|
Establish criteria for membership on the Board of Directors and
its Committees, such as depth of experience, business interest
and experience, required expertise and qualifications for
membership on each Committee;
|
|
|
|
Aid in recruiting and attracting qualified candidates to serve
on the Board;
|
|
|
|
Consider and appraise the performance of incumbent members of
the Board in determining whether to recommend that they be
nominated for re-election;
|
|
|
|
Make recommendations to the Board concerning (i) the size
and composition of the Board and (ii) the size and
composition of each standing Committee of the Board;
|
|
|
|
Recommend appointments of directors as members of Committees of
the Board;
|
|
|
|
Periodically review and recommend Governance Guidelines and
Policies, including, but not limited to: (i) recommending
the policy governing retirement of directors from the Board,
(ii) recommending the term of office for directors and
whether or not the Board should be classified according to
terms, (iii) recommending the desirable ratio of employee
and non-employee directors, and (iv) reviewing the format
and content of Board meetings and making recommendations for the
improvement of such meetings.
|
|
|
|
Approve the acceptance of outside Board seats by Company
executives;
|
|
|
|
Review the compensation of the members of the Board for services
as a director or member of any Committee of the Board and make
recommendations to the Board concerning the fixing of such
compensation;
|
C-1
|
|
|
|
|
Evaluate Company policies relating to the recruitment of
directors, including D&O insurance and indemnification and
make recommendations to the Board, or any appropriate Board
Committee, regarding such matters; and
|
|
|
|
Review periodically, in the light of changing conditions, new
legislation, regulations and other developments, the
Companys Code of Conduct, and make recommendations to the
Board for any changes, amendments and modifications to the Code
that the Committee shall deem desirable.
|
|
|
|
Review and report to the Board annually concerning Board member
independence as defined by the NASDAQ rules.
|
|
|
|
Annually, direct the evaluation of the functioning of the Board
in accordance with procedures established by the Board and make
recommendations to the Board on implementation of changes.
|
|
|
|
The Committee shall directly engage independent advisors when
deemed appropriate by the Committee.
|
C-2
APPENDIX D
DENTSPLY
INTERNATIONAL INC.
Human Resources Committee Charter
I. PURPOSE
The primary function of the Human Resources Committee is to
provide general oversight and assistance to the Board of
Directors of the Company (the Board) for the
organizational structure of the Company and the compensation and
hiring plans, policies and practices of the Company, including
specifically the compensation of the executive officers.
II. ORGANIZATION
|
|
A. |
Composition. The Committee shall
consist of directors who are independent, as defined by NASDAQ
and SEC rules, and are free from any relationship with the
Company or management of the Company that, in the opinion of the
Board as evidenced by its appointment of such Committee members,
would interfere with the exercise of independent judgment as a
Committee member.
|
|
|
B. |
Meetings. The Committee will meet as
often as necessary to carry out its responsibilities. Meetings
may be called by the Chairman of the Committee
and/or
management of the Company. A majority of the Committee shall
constitute a quorum. Written minutes of each meeting shall be
duly filed in the Company records. Reports of meetings of the
Committee shall be made to the Board accompanied by any
recommendations to the Board for matters that the Committee
determines requires approval of the Board.
|
III. FUNCTIONS
|
|
A. |
General. The Committees general
responsibility is to oversee the Companys employment,
hiring and compensation plans, personnel practices and policies,
and assure that the senior executives of the Company and its
wholly-owned affiliates are compensated effectively in a manner
consistent with the stated compensation strategy of the Company,
internal equity considerations, competitive practice, and the
requirements of the appropriate regulatory bodies. The Committee
shall communicate to shareholders, as deemed appropriate or as
required by the Securities and Exchange Commission or other
regulatory body, the Companys compensation policies and
practices. More specifically, the Committee shall be responsible
for the following:
|
|
|
|
|
|
Reviewing periodically the appointments, promotions and
performance of certain officers of the Company and the potential
successors of the principal executive officers of the Company,
as the Committee shall designate, and making recommendations to
the Board with respect to such matters to the extent it deems
appropriate;
|
|
|
|
Review from time to time and approve the Companys stated
compensation strategy to ensure that management is rewarded
appropriately for its contributions to Company growth and
profitability and that the executive compensation strategy
supports organization objectives and shareholder interests;
|
|
|
|
Review annually and determine the individual elements of total
compensation for the executive management of the Company and
communicate in the annual Board Compensation Committee Report to
shareholders the factors and criteria on which the executive
officers, including the Chief Executive Officers,
compensation for the last year was based;
|
|
|
|
Assure that the Companys executive incentive compensation
program(s) are administered in a manner consistent with the
Companys compensation strategy as to participation, target
annual incentive awards, corporate financial goals, and actual
awards paid to executive management;
|
|
|
|
Approve, subject to shareholders approval when appropriate, all
new equity-related incentive plans for senior management;
|
|
|
|
Recommend to the Board participants in the Companys
Supplemental Executive Retirement Plan;
|
D-1
|
|
|
|
|
Review the recruitment, hiring and promotion practices of the
Company and its subsidiaries in the light of applicable legal
requirements and corporate governance policies established by
the Board;
|
|
|
|
Receive and review annually or otherwise, as the Committee shall
deem appropriate, reports on significant matters and actions
taken in connection with the operation and administration of the
employee benefits plans of the Company and its subsidiaries;
|
|
|
|
Review with the Chief Executive Officer matters relating to
management succession;
|
|
|
|
If appropriate, hire experts in the field of executive
compensation and other matters related to the functions of the
Committee to assist the Committee with its areas of
responsibility; and
|
|
|
|
Such other duties and responsibilities as may be assigned to the
Committee, from time to time, by the Board of the Company, or as
designated in Company plan documents.
|
|
|
B.
|
Consultants. The Committee shall at all
times have the authority to retain and terminate any
compensation consultants or other advisors to assist it in any
aspect of the evaluation of executive compensation or on any
other subject relevant to the Committees responsibilities,
including the authority to approve such consultants or
advisors fees and other retention terms.
|
|
C.
|
Equity Compensation Plan. The Committee
shall administer the Equity Incentive Plans, including but not
limited to:
|
|
|
|
|
|
Consider relevant market data and Company and individual
performance relative to the types and size of awards;
|
|
|
|
Participating in the establishment of plan guidelines and
general size of overall grants;
|
|
|
|
Making grants;
|
|
|
|
Interpreting the Plans;
|
|
|
|
Determining rules and regulations relating to the Plans;
|
|
|
|
Modifying existing or canceling existing grants and substituting
new ones (with the consent of the grantees);
|
|
|
|
Approving any exceptions to receive retiree treatment; and
|
|
|
|
Authorizing foreign subsidiaries to adopt plans pursuant to the
provisions of the Plans.
|
D-2
|
|
|
|
|
|
|
|
|
VOTE BY INTERNET -
www.proxyvote.com
Use the Internet to transmit your voting
instructions and for electronic delivery of
information up until 11:59 P.M. Eastern Time the
day before the cut-off date or meeting date. Have
your proxy card in hand when you access the web
site and follow the instructions to obtain your
records and to create an electronic voting
instruction form.
ELECTRONIC DELIVERY OF FUTURE STOCKHOLDER COMMUNICATIONS
If you would like to reduce the costs incurred by
DENTSPLY International Inc. in mailing proxy
materials, you can consent to receiving all future
proxy statements, proxy cards and annual reports
electronically via e-mail or the Internet. To sign
up for electronic delivery, please follow the
instructions above to vote using the Internet and,
when prompted, indicate that you agree to receive
or access stockholder communications electronically
in future years.
VOTE BY PHONE - 1-800-690-6903
Use any touch-tone telephone to transmit your
voting instructions up until 11:59 P.M. Eastern
Time the day before the cut-off date or meeting
date. Have your proxy card in hand when you call
and then follow the instructions.
VOTE BY MAIL
Mark, sign and date your proxy card and return it
in the postage-paid envelope we have provided or
return it to DENTSPLY International Inc., c/o
Broadridge, 51 Mercedes Way, Edgewood, NY 11717.
|
|
|
|
|
|
TO VOTE, MARK BLOCKS BELOW
IN BLUE OR BLACK INK AS FOLLOWS: |
|
DNTSY1 |
|
KEEP THIS PORTION FOR YOUR RECORDS |
|
|
|
|
DETACH
AND RETURN THIS PORTION
ONLY |
THIS PROXY CARD IS VALID ONLY WHEN
SIGNED AND DATED.
|
|
|
|
|
|
|
|
|
|
|
|
|
DENTSPLY INTERNATIONAL INC. |
|
For All |
|
Withhold All |
|
For All Except |
|
To withhold authority to vote for any individual
nominee(s), mark For All Except and write the
number(s) of the nominee(s) on the line below.
|
|
The Board of Directors recommends a vote
FOR Proposals 1 and 2, and a vote
AGAINST Proposal 3.
Prop 1 Directors |
|
o |
|
o |
|
o |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
01) MICHAEL C. ALFANO
02) ERIC K. BRANDT
03) WILLIAM F. HECHT
04) FRANCIS J. LUNGER
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Vote on Proposals |
|
|
|
|
|
For |
|
Against |
|
Abstain |
|
|
|
|
|
|
|
|
|
|
Prop 2 |
PROPOSAL TO RATIFY THE APPOINTMENT OF PRICEWATERHOUSECOOPERS LLP, INDEPENDENT
ACCOUNTANTS, TO AUDIT THE BOOKS AND
ACCOUNTS OF THE COMPANY FOR THE YEAR ENDING DECEMBER 31, 2008.
|
|
o
|
|
o
|
|
o |
|
|
|
|
|
|
|
|
|
|
Prop 3 |
PROPOSAL REQUESTING THE BOARD OF DIRECTORS TO ISSUE A SUSTAINABILITY REPORT TO
STOCKHOLDERS BY SEPTEMBER 1, 2008. |
|
o
|
|
o
|
|
o |
|
|
|
|
|
|
|
|
|
|
*NOTE* SUCH OTHER BUSINESS AS MAY PROPERLY COME BEFORE THE MEETING OR ANY ADJOURNMENT THEREOF. |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For comments, please check this box and
write them on the back where indicated.
Please indicate if you plan to attend this meeting.
|
|
o
Yes |
|
o
No |
|
o |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Signature [PLEASE SIGN WITHIN BOX] |
Date |
|
|
|
|
|
Signature (Joint Owners) |
Date |
|
|
Important Notice Regarding Internet Availability of Proxy Materials for the Annual Meeting:
The Notice and Proxy Statement, Annual Report and Form 10-K are available at www.dentsply.com/proxy
IF
VOTING BY MAIL,
PLEASE RETURN PROXY CARD PROMPTLY
|
|
|
|
|
|
|
DO
NOT RETURN PROXY CARD IF YOU ARE VOTING BY INTERNET OR
TELEPHONE |
|
|
Solicited on behalf of the Board of Directors of
DENTSPLY International Inc.
The undersigned stockholder of DENTSPLY International Inc. (the Company) hereby appoints Brian M.
Addison as the attorney and proxy of the undersigned, with full power of substitution, to vote all
shares of Common Stock, par value $.01 per share, of the Company which the undersigned would be
entitled to vote if personally present at the Annual Meeting of Stockholders of the Company, to be
held at the Companys Employee Meeting Room at DENTSPLY International Inc., 570 West College
Avenue, York, Pennsylvania, on Tuesday, May 13, 2008, commencing at 9:30 a.m., local time, and at
any adjournment or postponement thereof, as indicated on the reverse side.
This proxy also provides voting instructions for shares held by T. Rowe Price Retirement Plan
Services, Inc., the trustee for the DENTSPLY International Inc. Employee Stock Ownership Plan (the
ESOP) and/or DENTSPLY International Inc. 401(k) Savings Plan (the 401 (k)), I hereby instruct
you to (a) vote the shares of Common Stock, par value $.01 per share (Common Stock) of DENTSPLY
International Inc. (the Company) allocated to the ESOP and/or 401(k) account in accordance with
the directions on the reverse side and (b) to grant a proxy to the proxy nominated by the Companys
Board of Directors authorizing him to vote in his discretion upon such other matters as may
properly come before the meeting.
This proxy/voting instruction card is solicited pursuant to a separate Notice of Annual Meeting and
Proxy Statement, receipt of which is hereby acknowledged. This card should be voted by mail,
Internet or telephone, in time to reach the Companys proxy tabulator, Broadridge Financial
Solutions, by 11:59 p.m. Eastern Time on Monday, May 12, 2008, for all registered shares to be
voted, and by 5:00 p.m. Eastern Time on Friday, May 9, 2008, for the Trustee to vote the Plan
shares.
(If you noted any Comments above, please mark corresponding box on the reverse side.)
|
|
|
|
(Continued and to be signed on reverse side) |
|